| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | OMB APPROVAL |
| OMB Number: 3235-0582 |
| Expires: July 31, 2024 |
| Estimated average burden |
| hours per response........4 |
FORM N-PX
ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY
Investment Company Act file number 811- 06565
Tekla Healthcare Opportunites Fund
(Exact name of registrant as specified in charter)
100 Federal Street, 19th Floor, Boston, MA | | 02110 |
(Address of principal executive offices) | | (Zip code) |
Laura Woodward
Tekla Healthcare Opportunities Fund
100 Federal Street, 19th Floor, Boston MA 02110
(Name and address of agent for service)
Registrant’s telephone number, including area code: 617-772-8500
Date of fiscal year end: September 30
Date of reporting period: 7/1/21-6/30/22
Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter), to file reports with the Commission, no later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.
Item 1. Proxy Voting Record.
Vote Summary
1LIFE HEALTHCARE, INC.
Security | 68269G107 | Meeting Type | Special |
Ticker Symbol | ONEM | Meeting Date | 27-Aug-2021 |
Record Date | 13-Jul-2021 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1. | | To approve the issuance of shares of common stock, $0.001 par value per share, of 1Life Healthcare, Inc. to stockholders of Iora Health, Inc. in connection with the merger contemplated by the Agreement and Plan of Merger, dated June 6, 2021, among 1Life Healthcare, Inc., SB Merger Sub, Inc., Iora Health, Inc. and Fortis Advisors LLC, solely in its capacity as the representative of the stockholders of Iora. | | Management | | For | | For | |
2. | | To approve adjournments of the 1Life special meeting, if necessary and appropriate, to solicit additional proxies if there are not sufficient votes to approve the 1Life stock issuance proposal. | | Management | | For | | For | |
1LIFE HEALTHCARE, INC.
Security | 68269G107 | Meeting Type | Annual |
Ticker Symbol | ONEM | Meeting Date | 02-Jun-2022 |
Record Date | 04-Apr-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1. | Paul R. Auvil | | | | For | | For | |
| | 2. | Mark S. Blumenkranz, MD | | | | For | | For | |
| | 3. | Kalen F. Holmes, Ph.D. | | | | For | | For | |
2. | | To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2022. | | Management | | For | | For | |
3. | | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | | Management | | For | | For | |
4. | | To approve, on a non-binding advisory basis, the frequency of future non-binding stockholder advisory votes on the compensation of our named executive officers. | | Management | | 1 Year | | For | |
ABBOTT LABORATORIES
Security | 002824100 | Meeting Type | Annual |
Ticker Symbol | ABT | Meeting Date | 29-Apr-2022 |
Record Date | 02-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1. | R. J. Alpern | | | | For | | For | |
| | 2. | S. E. Blount | | | | For | | For | |
| | 3. | R. B. Ford | | | | For | | For | |
| | 4. | P. Gonzalez | | | | For | | For | |
| | 5. | M. A. Kumbier | | | | For | | For | |
| | 6. | D. W. McDew | | | | For | | For | |
| | 7. | N. McKinstry | | | | For | | For | |
| | 8. | W. A. Osborn | | | | For | | For | |
| | 9. | M. F. Roman | | | | For | | For | |
| | 10. | D. J. Starks | | | | For | | For | |
| | 11. | J. G. Stratton | | | | For | | For | |
| | 12. | G. F. Tilton | | | | For | | For | |
2. | | Ratification of Ernst & Young LLP As Auditors | | Management | | For | | For | |
3. | | Say on Pay - An Advisory Vote on the Approval of Executive Compensation | | Management | | For | | For | |
4. | | Shareholder Proposal - Special Shareholder Meeting Threshold | | Shareholder | | Against | | For | |
5. | | Shareholder Proposal - Independent Board Chairman | | Shareholder | | For | | Against | |
6. | | Shareholder Proposal - Rule 10b5-1 Plans | | Shareholder | | Against | | For | |
7. | | Shareholder Proposal - Lobbying Disclosure | | Shareholder | | Against | | For | |
8. | | Shareholder Proposal - Antimicrobial Resistance Report | | Shareholder | | Against | | For | |
ABBVIE INC.
Security | 00287Y109 | Meeting Type | Annual |
Ticker Symbol | ABBV | Meeting Date | 06-May-2022 |
Record Date | 07-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1. | William H.L. Burnside | | | | For | | For | |
| | 2. | Thomas C. Freyman | | | | For | | For | |
| | 3. | Brett J. Hart | | | | For | | For | |
| | 4. | Edward J. Rapp | | | | For | | For | |
2. | | Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2022 | | Management | | For | | For | |
3. | | Say on Pay - An advisory vote on the approval of executive compensation | | Management | | For | | For | |
4. | | Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting | | Management | | For | | For | |
5. | | Stockholder Proposal - to Adopt a Policy to Require Independent Chairman | | Shareholder | | For | | Against | |
6. | | Stockholder Proposal - to Seek Shareholder Approval of Certain Termination Pay Arrangements | | Shareholder | | Against | | For | |
7. | | Stockholder Proposal - to Issue a Report on Board Oversight of Competition Practices | | Shareholder | | Against | | For | |
8. | | Stockholder Proposal - to Issue an Annual Report on Political Spending | | Shareholder | | Against | | For | |
ACADIA HEALTHCARE COMPANY, INC.
Security | 00404A109 | Meeting Type | Annual |
Ticker Symbol | ACHC | Meeting Date | 19-May-2022 |
Record Date | 24-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: Jason R. Bernhard | | Management | | For | | For | |
1B. | | Election of Director: William F. Grieco | | Management | | For | | For | |
1C. | | Election of Director: Reeve B. Waud | | Management | | For | | For | |
2. | | Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. | | Management | | For | | For | |
3. | | Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022. | | Management | | For | | For | |
ADDUS HOMECARE CORPORATION
Security | 006739106 | Meeting Type | Annual |
Ticker Symbol | ADUS | Meeting Date | 15-Jun-2022 |
Record Date | 22-Apr-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1. | Esteban López, M.D. | | | | For | | For | |
| | 2. | Jean Rush | | | | For | | For | |
| | 3. | Susan T. Weaver MD FACP | | | | For | | For | |
2. | | To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as our independent auditor for the fiscal year ending December 31, 2022. | | Management | | For | | For | |
3. | | To approve, on an advisory, non-binding basis, the compensation of the named executive officers. | | Management | | For | | For | |
AGILENT TECHNOLOGIES, INC.
Security | 00846U101 | Meeting Type | Annual |
Ticker Symbol | A | Meeting Date | 16-Mar-2022 |
Record Date | 18-Jan-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1.1 | | Election of Director for a three-year term: Hans E. Bishop | | Management | | For | | For | |
1.2 | | Election of Director for a three-year term: Otis W. Brawley, M.D. | | Management | | For | | For | |
1.3 | | Election of Director for a three-year term: Mikael Dolsten, M.D., Ph.D. | | Management | | For | | For | |
2. | | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | | Management | | For | | For | |
3. | | To ratify the Audit and Finance Committee's appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm. | | Management | | For | | For | |
4. | | To vote on a stockholder proposal regarding the right to call a special meeting, if properly presented at the meeting. | | Management | | Against | | For | |
ALERISLIFE, INC.
Security | 33832D205 | Meeting Type | Annual |
Ticker Symbol | ALR | Meeting Date | 07-Jun-2022 |
Record Date | 22-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1.1 | | Election of Director: Jennifer B. Clark (for Managing Director in Group III) | | Management | | For | | For | |
1.2 | | Election of Director: Bruce M. Gans, M.D. (for Independent Director in Group III) | | Management | | For | | For | |
1.3 | | Election of Director: Michael E. Wagner, M.D. (for Independent Director in Group III) | | Management | | For | | For | |
2. | | Approval of the Second Amended and Restated 2014 Equity Compensation Plan. | | Management | | For | | For | |
3. | | Ratification of the appointment of Deloitte & Touche LLP as independent auditors to serve for the 2022 fiscal year. | | Management | | For | | For | |
ALIGN TECHNOLOGY, INC.
Security | 016255101 | Meeting Type | Annual |
Ticker Symbol | ALGN | Meeting Date | 18-May-2022 |
Record Date | 23-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1a. | | Election of Director: Kevin J. Dallas | | Management | | For | | For | |
1b. | | Election of Director: Joseph M. Hogan | | Management | | For | | For | |
1c. | | Election of Director: Joseph Lacob | | Management | | For | | For | |
1d. | | Election of Director: C. Raymond Larkin, Jr. | | Management | | For | | For | |
1e. | | Election of Director: George J. Morrow | | Management | | For | | For | |
1f. | | Election of Director: Anne M. Myong | | Management | | For | | For | |
1g. | | Election of Director: Andrea L. Saia | | Management | | For | | For | |
1h. | | Election of Director: Greg J. Santora | | Management | | For | | For | |
1i. | | Election of Director: Susan E. Siegel | | Management | | For | | For | |
1j. | | Election of Director: Warren S. Thaler | | Management | | For | | For | |
2. | | RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS: Proposal to ratify the appointment of PricewaterhouseCoopers LLP as Align Technology, Inc.'s independent registered public accountants for the fiscal year ending December 31, 2022. | | Management | | For | | For | |
3. | | ADVISORY VOTE ON NAMED EXECUTIVES COMPENSATION: Consider an Advisory Vote to Approve the Compensation of our Named Executive Officers. | | Management | | For | | For | |
AMGEN, INC.
Security | 031162100 | Meeting Type | Annual |
Ticker Symbol | AMGN | Meeting Date | 17-May-2022 |
Record Date | 18-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director for a term of expiring at the 2023 annual meeting: Dr. Wanda M. Austin | | Management | | For | | For | |
1B. | | Election of Director for a term of expiring at the 2023 annual meeting: Mr. Robert A. Bradway | | Management | | For | | For | |
1C. | | Election of Director for a term of expiring at the 2023 annual meeting: Dr. Brian J. Druker | | Management | | For | | For | |
1D. | | Election of Director for a term of expiring at the 2023 annual meeting: Mr. Robert A. Eckert | | Management | | For | | For | |
1E. | | Election of Director for a term of expiring at the 2023 annual meeting: Mr. Greg C. Garland | | Management | | For | | For | |
1F. | | Election of Director for a term of expiring at the 2023 annual meeting: Mr. Charles M. Holley, Jr. | | Management | | For | | For | |
1G. | | Election of Director for a term of expiring at the 2023 annual meeting: Dr. S. Omar Ishrak | | Management | | For | | For | |
1H. | | Election of Director for a term of expiring at the 2023 annual meeting: Dr. Tyler Jacks | | Management | | For | | For | |
1I. | | Election of Director for a term of expiring at the 2023 annual meeting: Ms. Ellen J. Kullman | | Management | | For | | For | |
1J. | | Election of Director for a term of expiring at the 2023 annual meeting: Ms. Amy E. Miles | | Management | | For | | For | |
1K. | | Election of Director for a term of expiring at the 2023 annual meeting: Dr. Ronald D. Sugar | | Management | | For | | For | |
1L. | | Election of Director for a term of expiring at the 2023 annual meeting: Dr. R. Sanders Williams | | Management | | For | | For | |
2. | | Advisory vote to approve our executive compensation. | | Management | | For | | For | |
3. | | To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2022. | | Management | | For | | For | |
AMN HEALTHCARE SERVICES, INC.
Security | 001744101 | Meeting Type | Annual |
Ticker Symbol | AMN | Meeting Date | 06-May-2022 |
Record Date | 14-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: Jorge A. Caballero | | Management | | For | | For | |
1B. | | Election of Director: Mark G. Foletta | | Management | | For | | For | |
1C. | | Election of Director: Teri G. Fontenot | | Management | | For | | For | |
1D. | | Election of Director: R. Jeffrey Harris | | Management | | For | | For | |
1E. | | Election of Director: Daphne E. Jones | | Management | | For | | For | |
1F. | | Election of Director: Martha H. Marsh | | Management | | For | | For | |
1G. | | Election of Director: Susan R. Salka | | Management | | For | | For | |
1H. | | Election of Director: Sylvia Trent-Adams | | Management | | For | | For | |
1I. | | Election of Director: Douglas D. Wheat | | Management | | For | | For | |
2. | | To approve, by non-binding advisory vote, the compensation of the Company's named executive officers. | | Management | | For | | For | |
3. | | To approve the AMN Healthcare Employee Stock Purchase Plan. | | Management | | For | | For | |
4. | | To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022. | | Management | | For | | For | |
5. | | A shareholder proposal entitled: "Special Shareholder Meeting Improvement". | | Shareholder | | Against | | For | |
Security | 036752103 | Meeting Type | Annual |
Ticker Symbol | ANTM | Meeting Date | 18-May-2022 |
Record Date | 17-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1.1 | | Election of Director: Susan D. DeVore | | Management | | For | | For | |
1.2 | | Election of Director: Bahija Jallal | | Management | | For | | For | |
1.3 | | Election of Director: Ryan M. Schneider | | Management | | For | | For | |
1.4 | | Election of Director: Elizabeth E. Tallett | | Management | | For | | For | |
2. | | Advisory vote to approve the compensation of our named executive officers. | | Management | | For | | For | |
3. | | To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2022. | | Management | | For | | For | |
4. | | To approve an amendment to our Articles of Incorporation to change our name to Elevance Health, Inc. | | Management | | For | | For | |
5. | | Shareholder proposal to prohibit political funding. | | Shareholder | | Against | | For | |
6. | | Shareholder proposal requesting a racial impact audit and report. | | Shareholder | | Against | | For | |
Security | 04546C205 | Meeting Type | Annual |
Ticker Symbol | ASRT | Meeting Date | 04-May-2022 |
Record Date | 28-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1.1 | | Election of Director to serve until the 2023 Annual Meeting of Stockholders: Heather L. Mason | | Management | | For | | For | |
1.2 | | Election of Director to serve until the 2023 Annual Meeting of Stockholders: William T. McKee | | Management | | For | | For | |
1.3 | | Election of Director to serve until the 2023 Annual Meeting of Stockholders: Daniel A. Peisert | | Management | | For | | For | |
1.4 | | Election of Director to serve until the 2023 Annual Meeting of Stockholders: Peter D. Staple | | Management | | For | | For | |
1.5 | | Election of Director to serve until the 2023 Annual Meeting of Stockholders: James L. Tyree | | Management | | For | | For | |
2. | | To approve an amendment and restatement of Assertio's Amended and Restated 2014 Omnibus Incentive Plan, including an increase in the number of shares available for issuance thereunder. | | Management | | For | | For | |
3. | | To approve, on an advisory basis, the compensation of Assertio's named executive officers. | | Management | | For | | For | |
4. | | To ratify the appointment of Grant Thornton LLP as Assertio's independent registered public accounting firm for the fiscal year ending December 31, 2022. | | Management | | For | | For | |
Security | 046353108 | Meeting Type | Annual |
Ticker Symbol | AZN | Meeting Date | 29-Apr-2022 |
Record Date | 07-Apr-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1. | | To receive the Company's Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended 31 December 2021 | | Management | | For | | For | |
2. | | To confirm dividends | | Management | | For | | For | |
3. | | To reappoint PricewaterhouseCoopers LLP as Auditor | | Management | | For | | For | |
4. | | To authorise the Directors to agree the remuneration of the Auditor | | Management | | For | | For | |
5A. | | Re-election of Director: Leif Johansson | | Management | | For | | For | |
5B. | | Re-election of Director: Pascal Soriot | | Management | | For | | For | |
5C. | | Election of Director: Aradhana Sarin | | Management | | For | | For | |
5D. | | Re-election of Director: Philip Broadley | | Management | | For | | For | |
5E. | | Re-election of Director: Euan Ashley | | Management | | For | | For | |
5F. | | Re-election of Director: Michel Demaré | | Management | | For | | For | |
5G. | | Re-election of Director: Deborah DiSanzo | | Management | | For | | For | |
5H. | | Re-election of Director: Diana Layfield | | Management | | For | | For | |
5I. | | Re-election of Director: Sheri McCoy | | Management | | For | | For | |
5J. | | Re-election of Director: Tony Mok | | Management | | For | | For | |
5K. | | Re-election of Director: Nazneen Rahman | | Management | | For | | For | |
5L. | | Election of Director: Andreas Rummelt | | Management | | For | | For | |
5M. | | Re-election of Director: Marcus Wallenberg | | Management | | For | | For | |
6. | | To approve the Annual Report on Remuneration for the year ended 31 December 2021 | | Management | | For | | For | |
7. | | To authorise limited political donations | | Management | | For | | For | |
8. | | To authorise the Directors to allot shares | | Management | | For | | For | |
9. | | To authorise the Directors to disapply pre-emption rights (Special Resolution) | | Management | | For | | For | |
10. | | To authorise the Directors to further disapply pre-emption rights for acquisitions and specified capital investments (Special Resolution) | | Management | | For | | For | |
11. | | To authorise the Company to purchase its own shares (Special Resolution) | | Management | | For | | For | |
12. | | To reduce the notice period for general meetings (Special Resolution) | | Management | | For | | For | |
13. | | To extend the AstraZenca PLC 2012 Savings Related Share Option Scheme | | Management | | For | | For | |
BECTON, DICKINSON AND COMPANY
Security | 075887109 | Meeting Type | Annual |
Ticker Symbol | BDX | Meeting Date | 25-Jan-2022 |
Record Date | 06-Dec-2021 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: Catherine M. Burzik | | Management | | For | | For | |
1B. | | Election of Director: Carrie L. Byington | | Management | | For | | For | |
1C. | | Election of Director: R. Andrew Eckert | | Management | | For | | For | |
1D. | | Election of Director: Claire M. Fraser | | Management | | For | | For | |
1E. | | Election of Director: Jeffrey W. Henderson | | Management | | For | | For | |
1F. | | Election of Director: Christopher Jones | | Management | | For | | For | |
1G. | | Election of Director: Marshall O. Larsen | | Management | | For | | For | |
1H. | | Election of Director: David F. Melcher | | Management | | For | | For | |
1I. | | Election of Director: Thomas E. Polen | | Management | | For | | For | |
1J. | | Election of Director: Claire Pomeroy | | Management | | For | | For | |
1K. | | Election of Director: Timothy M. Ring | | Management | | For | | For | |
1L. | | Election of Director: Bertram L. Scott | | Management | | For | | For | |
2. | | Ratification of the selection of the independent registered public accounting firm. | | Management | | For | | For | |
3. | | Advisory vote to approve named executive officer compensation. | | Management | | For | | For | |
4. | | A shareholder proposal seeking to lower the ownership threshold required to call a special shareholders meeting, if properly presented at the meeting. | | Shareholder | | Against | | For | |
Security | 09073M104 | Meeting Type | Annual |
Ticker Symbol | TECH | Meeting Date | 28-Oct-2021 |
Record Date | 03-Sep-2021 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1. | | To set the number of Directors at nine. | | Management | | For | | For | |
2A. | | Election of Director: Robert V. Baumgartner | | Management | | For | | For | |
2B. | | Election of Director: Julie L. Bushman | | Management | | For | | For | |
2C. | | Election of Director: John L. Higgins | | Management | | For | | For | |
2D. | | Election of Director: Joseph D. Keegan | | Management | | For | | For | |
2E. | | Election of Director: Charles R. Kummeth | | Management | | For | | For | |
2F. | | Election of Director: Roeland Nusse | | Management | | For | | For | |
2G. | | Election of Director: Alpna Seth | | Management | | For | | For | |
2H. | | Election of Director: Randolph Steer | | Management | | For | | For | |
2I. | | Election of Director: Rupert Vessey | | Management | | For | | For | |
3. | | Cast a non-binding vote on named executive officer compensation. | | Management | | For | | For | |
4. | | Ratify the appointment of the Company's independent registered public accounting firm for the 2022 fiscal year. | | Management | | For | | For | |
Security | 09062X103 | Meeting Type | Annual |
Ticker Symbol | BIIB | Meeting Date | 15-Jun-2022 |
Record Date | 21-Apr-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1a. | | Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Alexander J. Denner | | Management | | For | | For | |
1b. | | Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Caroline D. Dorsa | | Management | | For | | For | |
1c. | | Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Maria C. Freire | | Management | | For | | For | |
1d. | | Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: William A. Hawkins | | Management | | For | | For | |
1e. | | Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: William D. Jones | | Management | | For | | For | |
1f. | | Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Jesus B. Mantas | | Management | | For | | For | |
1g. | | Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Richard C. Mulligan | | Management | | For | | For | |
1h. | | Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Stelios Papadopoulos | | Management | | For | | For | |
1i. | | Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Eric K. Rowinsky | | Management | | For | | For | |
1j. | | Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Stephen A. Sherwin | | Management | | For | | For | |
1k. | | Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Michel Vounatsos | | Management | | For | | For | |
2. | | To ratify the selection of PricewaterhouseCoopers LLP as Biogen Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2022. | | Management | | For | | For | |
3. | | Say on Pay - To approve an advisory vote on executive compensation. | | Management | | For | | For | |
BOSTON SCIENTIFIC CORPORATION |
Security | 101137107 | Meeting Type | Annual |
Ticker Symbol | BSX | Meeting Date | 05-May-2022 |
Record Date | 11-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: Nelda J. Connors | | Management | | For | | For | |
1B. | | Election of Director: Charles J. Dockendorff | | Management | | For | | For | |
1C. | | Election of Director: Yoshiaki Fujimori | | Management | | For | | For | |
1D. | | Election of Director: Donna A. James | | Management | | For | | For | |
1E. | | Election of Director: Edward J. Ludwig | | Management | | For | | For | |
1F. | | Election of Director: Michael F. Mahoney | | Management | | For | | For | |
1G. | | Election of Director: David J. Roux | | Management | | For | | For | |
1H. | | Election of Director: John E. Sununu | | Management | | For | | For | |
1I. | | Election of Director: David S. Wichmann | | Management | | For | | For | |
1J. | | Election of Director: Ellen M. Zane | | Management | | For | | For | |
2. | | To approve, on a non-binding, advisory basis, named executive officer compensation. | | Management | | For | | For | |
3. | | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2022 fiscal year. | | Management | | For | | For | |
4. | | To approve an amendment and restatement of our 2006 Global Employee Stock Ownership Plan (to be renamed as our Employee Stock Purchase Plan), as previously amended and restated, including a request for 10,000,000 additional shares. | | Management | | For | | For | |
BRISTOL-MYERS SQUIBB COMPANY |
Security | 110122108 | Meeting Type | Annual |
Ticker Symbol | BMY | Meeting Date | 03-May-2022 |
Record Date | 14-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A) | | Election of Director: Peter J. Arduini | | Management | | For | | For | |
1B) | | Election of Director: Giovanni Caforio, M.D. | | Management | | For | | For | |
1C) | | Election of Director: Julia A. Haller, M.D. | | Management | | For | | For | |
1D) | | Election of Director: Manuel Hidalgo Medina, M.D., Ph.D. | | Management | | For | | For | |
1E) | | Election of Director: Paula A. Price | | Management | | For | | For | |
1F) | | Election of Director: Derica W. Rice | | Management | | For | | For | |
1G) | | Election of Director: Theodore R. Samuels | | Management | | For | | For | |
1H) | | Election of Director: Gerald L. Storch | | Management | | For | | For | |
1I) | | Election of Director: Karen H. Vousden, Ph.D. | | Management | | For | | For | |
1J) | | Election of Director: Phyllis R. Yale | | Management | | For | | For | |
2. | | Advisory Vote to Approve the Compensation of our Named Executive Officers. | | Management | | For | | For | |
3. | | Ratification of the Appointment of an Independent Registered Public Accounting Firm. | | Management | | For | | For | |
4. | | Shareholder Proposal to Lower the Ownership Threshold for Special Shareholder Meetings to 10%. | | Shareholder | | Against | | For | |
5. | | Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director. | | Shareholder | | For | | Against | |
Security | 148806102 | Meeting Type | Annual |
Ticker Symbol | CTLT | Meeting Date | 28-Oct-2021 |
Record Date | 03-Sep-2021 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: Madhavan Balachandran | | Management | | For | | For | |
1B. | | Election of Director: Michael J. Barber | | Management | | For | | For | |
1C. | | Election of Director: J. Martin Carroll | | Management | | For | | For | |
1D. | | Election of Director: John Chiminski | | Management | | For | | For | |
1E. | | Election of Director: Rolf Classon | | Management | | For | | For | |
1F. | | Election of Director: Rosemary A. Crane | | Management | | For | | For | |
1G. | | Election of Director: John Greisch | | Management | | For | | For | |
1H. | | Election of Director: Christa Kreuzburg | | Management | | For | | For | |
1I. | | Election of Director: Gregory T. Lucier | | Management | | For | | For | |
1J. | | Election of Director: Donald E. Morel, Jr. | | Management | | For | | For | |
1K. | | Election of Director: Jack Stahl | | Management | | For | | For | |
2. | | Ratification of Appointment of Independent Auditor for Fiscal 2022. | | Management | | For | | For | |
3. | | Advisory Vote to Approve Our Executive Compensation (Say-on-Pay). | | Management | | For | | For | |
4. | | Advisory Vote on the Frequency of Advisory Votes in Respect of Executive Compensation. | | Management | | 1 Year | | For | |
5. | | Amend our Certificate of Incorporation to Remove the Limitation on Calling Shareholder Special Meetings. | | Management | | For | | For | |
6. | | Amend our Certificate of Incorporation to Add a Federal Forum Selection Provision. | | Management | | For | | For | |
7. | | Amend and Restate our Certificate of Incorporation to (i) Eliminate the Supermajority Vote Requirement for Amendments and (ii) Make Non-Substantive and Conforming Changes. | | Management | | For | | For | |
CHARLES RIVER LABORATORIES INTL., INC.
Security | 159864107 | Meeting Type | Annual |
Ticker Symbol | CRL | Meeting Date | 10-May-2022 |
Record Date | 21-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: James C. Foster | | Management | | For | | For | |
1B. | | Election of Director: Nancy C. Andrews | | Management | | For | | For | |
1C. | | Election of Director: Robert Bertolini | | Management | | For | | For | |
1D. | | Election of Director: Deborah T. Kochevar | | Management | | For | | For | |
1E. | | Election of Director: George Llado, Sr. | | Management | | For | | For | |
1F. | | Election of Director: Martin W. MacKay | | Management | | For | | For | |
1G. | | Election of Director: George E. Massaro | | Management | | For | | For | |
1H. | | Election of Director: C. Richard Reese | | Management | | For | | For | |
1I. | | Election of Director: Richard F. Wallman | | Management | | For | | For | |
1J. | | Election of Director: Virginia M. Wilson | | Management | | For | | For | |
2. | | Advisory approval of 2021 Executive Compensation | | Management | | For | | For | |
3. | | Ratification of PricewaterhouseCoopers LLC as independent registered accounting public firm for 2022 | | Management | | For | | For | |
Security | 125523100 | Meeting Type | Annual |
Ticker Symbol | CI | Meeting Date | 27-Apr-2022 |
Record Date | 08-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: David M. Cordani | | Management | | For | | For | |
1B. | | Election of Director: William J. DeLaney | | Management | | For | | For | |
1C. | | Election of Director: Eric J. Foss | | Management | | For | | For | |
1D. | | Election of Director: Elder Granger, MD, MG, USA (Retired) | | Management | | For | | For | |
1E. | | Election of Director: Neesha Hathi | | Management | | For | | For | |
1F. | | Election of Director: George Kurian | | Management | | For | | For | |
1G. | | Election of Director: Kathleen M. Mazzarella | | Management | | For | | For | |
1H. | | Election of Director: Mark B. McClellan, MD, PhD | | Management | | For | | For | |
1I. | | Election of Director: Kimberly A. Ross | | Management | | For | | For | |
1J. | | Election of Director: Eric C. Wiseman | | Management | | For | | For | |
1K. | | Election of Director: Donna F. Zarcone | | Management | | For | | For | |
2. | | Advisory approval of Cigna's executive compensation. | | Management | | For | | For | |
3. | | Ratification of the appointment of PricewaterhouseCoopers LLP as Cigna's independent registered public accounting firm for 2022. | | Management | | For | | For | |
4. | | Shareholder proposal - Special shareholder meeting improvement. | | Shareholder | | Against | | For | |
5. | | Shareholder proposal - Gender pay gap report. | | Shareholder | | Against | | For | |
6. | | Shareholder proposal - Political contributions report. | | Shareholder | | Against | | For | |
COMMUNITY HEALTH SYSTEMS, INC. |
Security | 203668108 | Meeting Type | Annual |
Ticker Symbol | CYH | Meeting Date | 10-May-2022 |
Record Date | 14-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: Susan W. Brooks | | Management | | For | | For | |
1B. | | Election of Director: John A. Clerico | | Management | | For | | For | |
1C. | | Election of Director: Michael Dinkins | | Management | | For | | For | |
1D. | | Election of Director: James S. Ely III | | Management | | For | | For | |
1E. | | Election of Director: John A. Fry | | Management | | For | | For | |
1F. | | Election of Director: Joseph A. Hastings, D.M.D. | | Management | | For | | For | |
1G. | | Election of Director: Tim L. Hingtgen | | Management | | For | | For | |
1H. | | Election of Director: Elizabeth T. Hirsch | | Management | | For | | For | |
1I. | | Election of Director: William Norris Jennings, M.D. | | Management | | For | | For | |
1J. | | Election of Director: K. Ranga Krishnan, MBBS | | Management | | For | | For | |
1K. | | Election of Director: Wayne T. Smith | | Management | | For | | For | |
1L. | | Election of Director: H. James Williams, Ph.D. | | Management | | For | | For | |
2. | | Proposal to approve on an advisory (non-binding) basis the compensation of the Company's named executive officers. | | Management | | For | | For | |
3. | | Proposal to ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022. | | Management | | For | | For | |
Security | 126650100 | Meeting Type | Annual |
Ticker Symbol | CVS | Meeting Date | 11-May-2022 |
Record Date | 14-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: Fernando Aguirre | | Management | | For | | For | |
1B. | | Election of Director: C. David Brown II | | Management | | For | | For | |
1C. | | Election of Director: Alecia A. DeCoudreaux | | Management | | For | | For | |
1D. | | Election of Director: Nancy-Ann M. DeParle | | Management | | For | | For | |
1E. | | Election of Director: Roger N. Farah | | Management | | For | | For | |
1F. | | Election of Director: Anne M. Finucane | | Management | | For | | For | |
1G. | | Election of Director: Edward J. Ludwig | | Management | | For | | For | |
1H. | | Election of Director: Karen S. Lynch | | Management | | For | | For | |
1I. | | Election of Director: Jean-Pierre Millon | | Management | | For | | For | |
1J. | | Election of Director: Mary L. Schapiro | | Management | | For | | For | |
1K. | | Election of Director: William C. Weldon | | Management | | For | | For | |
2. | | Ratification of the appointment of our independent registered public accounting firm for 2022. | | Management | | For | | For | |
3. | | Say on Pay, a proposal to approve, on an advisory basis, the Company's executive compensation. | | Management | | For | | For | |
4. | | Stockholder proposal for reducing our ownership threshold to request a special stockholder meeting. | | Shareholder | | Against | | For | |
5. | | Stockholder proposal regarding our independent Board Chair. | | Shareholder | | For | | Against | |
6. | | Stockholder proposal on civil rights and non- discrimination audit focused on "non-diverse" employees. | | Shareholder | | Against | | For | |
7. | | Stockholder proposal requesting paid sick leave for all employees. | | Shareholder | | Against | | For | |
8. | | Stockholder proposal regarding a report on the public health costs of our food business to diversified portfolios. | | Shareholder | | Against | | For | |
Security | 235851102 | Meeting Type | Annual |
Ticker Symbol | DHR | Meeting Date | 10-May-2022 |
Record Date | 11-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Rainer M. Blair | | Management | | For | | For | |
1B. | | Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Linda Filler | | Management | | For | | For | |
1C. | | Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Teri List | | Management | | For | | For | |
1D. | | Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Walter G. Lohr, Jr. | | Management | | For | | For | |
1E. | | Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Jessica L. Mega, MD, MPH | | Management | | For | | For | |
1F. | | Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Mitchell P. Rales | | Management | | For | | For | |
1G. | | Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Steven M. Rales | | Management | | For | | For | |
1H. | | Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Pardis C. Sabeti, MD, D. PHIL | | Management | | For | | For | |
1I. | | Election of Director to hold office until the 2023 Annual Meeting of Shareholders: A. Shane Sanders | | Management | | For | | For | |
1J. | | Election of Director to hold office until the 2023 Annual Meeting of Shareholders: John T. Schwieters | | Management | | For | | For | |
1K. | | Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Alan G. Spoon | | Management | | For | | For | |
1L. | | Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Raymond C. Stevens, Ph.D | | Management | | For | | For | |
1M. | | Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Elias A. Zerhouni, MD | | Management | | For | | For | |
2. | | To ratify the selection of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2022. | | Management | | For | | For | |
3. | | To approve on an advisory basis the Company's named executive officer compensation. | | Management | | For | | For | |
4. | | To act upon a shareholder proposal requesting that Danaher amend its governing documents to reduce the percentage of shares required for shareholders to call a special meeting of shareholders from 25% to 10%. | | Shareholder | | Against | | For | |
DENTSPLY SIRONA INC.
Security | 24906P109 | Meeting Type | Annual |
Ticker Symbol | XRAY | Meeting Date | 25-May-2022 |
Record Date | 28-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: Eric K. Brandt | | Management | | For | | For | |
1B. | | Election of Director: Donald M. Casey Jr. | | Management | | For | | For | |
1C. | | Election of Director: Willie A. Deese | | Management | | For | | For | |
1D. | | Election of Director: John P. Groetelaars | | Management | | For | | For | |
1E. | | Election of Director: Betsy D. Holden | | Management | | For | | For | |
1F. | | Election of Director: Clyde R. Hosein | | Management | | For | | For | |
1G. | | Election of Director: Harry M. Kraemer Jr. | | Management | | For | | For | |
1H. | | Election of Director: Gregory T. Lucier | | Management | | For | | For | |
1I. | | Election of Director: Leslie F. Varon | | Management | | For | | For | |
1J. | | Election of Director: Janet S. Vergis | | Management | | For | | For | |
1K. | | Election of Director: Dorothea Wenzel | | Management | | For | | For | |
2. | | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accountants for 2022. | | Management | | For | | For | |
3. | | Approval, by non-binding vote, of the Company's executive compensation. | | Management | | For | | For | |
4. | | Approval of the Amendment to the Fifth Amended and Restated By- Laws to Designate the Exclusive Forum for the Adjudication of Certain Legal Matters. | | Management | | For | | For | |
Security | 252131107 | Meeting Type | Annual |
Ticker Symbol | DXCM | Meeting Date | 19-May-2022 |
Record Date | 31-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1.1 | | Election of Class II Director to hold office until our 2023 Annual Meeting: Steven R. Altman | | Management | | For | | For | |
1.2 | | Election of Class II Director to hold office until our 2023 Annual Meeting: Barbara E. Kahn | | Management | | For | | For | |
1.3 | | Election of Class II Director to hold office until our 2023 Annual Meeting: Kyle Malady | | Management | | For | | For | |
1.4 | | Election of Class II Director to hold office until our 2023 Annual Meeting: Jay S. Skyler, MD, MACP | | Management | | For | | For | |
2. | | To ratify the selection by the Audit Committee of our Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022. | | Management | | For | | For | |
3. | | To hold a non-binding vote on an advisory resolution to approve executive compensation. | | Management | | For | | For | |
4. | | To approve the amendment and restatement of our Restated Certificate of Incorporation to (i) effect a 4:1 forward split of our Common Stock (the "Forward Stock Split") and (ii) increase the number of shares of authorized Common Stock to effectuate the Forward Stock Split. | | Management | | For | | For | |
DIVERSIFIED HEALTHCARE TRUST |
Security | 25525P107 | Meeting Type | Annual |
Ticker Symbol | DHC | Meeting Date | 02-Jun-2022 |
Record Date | 22-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Independent Trustee: Lisa Harris Jones | | Management | | For | | For | |
1B. | | Election of Independent Trustee: John L. Harrington | | Management | | For | | For | |
1C. | | Election of Managing Trustee: Jennifer F. Francis | | Management | | For | | For | |
1D. | | Election of Managing Trustee: Adam D. Portnoy | | Management | | For | | For | |
2. | | Advisory vote to approve executive compensation. | | Management | | For | | For | |
3. | | Approval of the Amended and Restated 2012 Equity Compensation Plan. | | Management | | For | | For | |
4. | | Ratification of the appointment of Deloitte & Touche LLP as independent auditors to serve for the 2022 fiscal year. | | Management | | For | | For | |
EDWARDS LIFESCIENCES CORPORATION |
Security | 28176E108 | Meeting Type | Annual |
Ticker Symbol | EW | Meeting Date | 03-May-2022 |
Record Date | 09-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1.1 | | Election of Director: Kieran T. Gallahue | | Management | | For | | For | |
1.2 | | Election of Director: Leslie S. Heisz | | Management | | For | | For | |
1.3 | | Election of Director: Paul A. LaViolette | | Management | | For | | For | |
1.4 | | Election of Director: Steven R. Loranger | | Management | | For | | For | |
1.5 | | Election of Director: Martha H. Marsh | | Management | | For | | For | |
1.6 | | Election of Director: Michael A. Mussallem | | Management | | For | | For | |
1.7 | | Election of Director: Ramona Sequeira | | Management | | For | | For | |
1.8 | | Election of Director: Nicholas J. Valeriani | | Management | | For | | For | |
2. | | Advisory Vote to Approve Named Executive Officer Compensation | | Management | | For | | For | |
3. | | Ratification of Appointment of Independent Registered Public Accounting Firm | | Management | | For | | For | |
4. | | Stockholder Proposal for an Advisory Vote to Reduce the Share Ownership Threshold to Call a Special Meeting | | Shareholder | | Against | | For | |
Security | 532457108 | Meeting Type | Annual |
Ticker Symbol | LLY | Meeting Date | 02-May-2022 |
Record Date | 22-Feb-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director to serve a three-year term: Ralph Alvarez | | Management | | For | | For | |
1B. | | Election of Director to serve a three-year term: Kimberly H. Johnson | | Management | | For | | For | |
1C. | | Election of Director to serve a three-year term: Juan R. Luciano | | Management | | For | | For | |
2. | | Approval, on an advisory basis, of the compensation paid to the company's named executive officers. | | Management | | For | | For | |
3. | | Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2022. | | Management | | For | | For | |
4. | | Approval of amendments to the company's Articles of Incorporation to eliminate the classified board structure. | | Management | | For | | For | |
5. | | Approval of amendments to the company's Articles of Incorporation to eliminate supermajority voting provisions. | | Management | | For | | For | |
6. | | Approval of amendments to the company's Articles of Incorporation to give shareholders the ability to amend the company's bylaws. | | Management | | For | | For | |
7. | | Shareholder proposal to amend the bylaws to require an independent board chair. | | Shareholder | | For | | Against | |
8. | | Shareholder proposal to publish an annual report disclosing lobbying activities. | | Shareholder | | Against | | For | |
9. | | Shareholder proposal to disclose lobbying activities and alignment with public policy positions and statements. | | Shareholder | | Against | | For | |
10. | | Shareholder proposal to report oversight of risks related to anticompetitive pricing strategies. | | Shareholder | | Against | | For | |
ENDEAVOR BIOMEDICINES, INC. |
Security | N/A | Meeting Type | Written Consent |
Ticker Symbol | N/A | Meeting Date | 03-Mar-2022 |
Record Date | N/A | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1. | | Amendment to Amended and Restated Certificate of Incorporation. | | Management | | For | | For | |
2. | | Amendment to Series B Preferred Stock Purchase Agreement. | | Management | | For | | For | |
3. | | General Authority and Ratification. | | Management | | For | | For | |
GALERA THERAPEUTICS, INC. |
Security | 36338D108 | Meeting Type | Annual |
Ticker Symbol | GRTX | Meeting Date | 15-Jun-2022 |
Record Date | 22-Apr-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1. | Emmett Cunningham | | | | For | | For | |
| | 2. | J. Mel Sorensen | | | | For | | For | |
2. | | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022. | | Management | | For | | For | |
Security | 375558103 | Meeting Type | Annual |
Ticker Symbol | GILD | Meeting Date | 04-May-2022 |
Record Date | 15-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: Jacqueline K. Barton, Ph.D. | | Management | | For | | For | |
1B. | | Election of Director: Jeffrey A. Bluestone, Ph.D. | | Management | | For | | For | |
1C. | | Election of Director: Sandra J. Horning, M.D. | | Management | | For | | For | |
1D. | | Election of Director: Kelly A. Kramer | | Management | | For | | For | |
1E. | | Election of Director: Kevin E. Lofton | | Management | | For | | For | |
1F. | | Election of Director: Harish Manwani | | Management | | For | | For | |
1G. | | Election of Director: Daniel P. O'Day | | Management | | For | | For | |
1H. | | Election of Director: Javier J. Rodriguez | | Management | | For | | For | |
1I. | | Election of Director: Anthony Welters | | Management | | For | | For | |
2. | | To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022. | | Management | | For | | For | |
3. | | To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement. | | Management | | For | | For | |
4. | | To approve the Gilead Sciences, Inc. 2022 Equity Incentive Plan. | | Management | | For | | For | |
5. | | To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board adopt a policy that the Chairperson of the Board of Directors be an independent director. | | Shareholder | | Against | | For | |
6. | | To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board include one member from Gilead's non-management employees. | | Shareholder | | Against | | For | |
7. | | To vote on a stockholder proposal, if properly presented at the meeting, requesting a 10% threshold to call a special stockholder meeting. | | Shareholder | | Against | | For | |
8. | | To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board publish a third- party review of Gilead's lobbying activities. | | Shareholder | | Against | | For | |
9. | | To vote on a stockholder proposal, if properly presented at the meeting, requesting a Board report on oversight of risks related to anticompetitive practices. | | Shareholder | | Against | | For | |
GLOBAL MEDICAL REIT, INC.
Security | 37954A204 | Meeting Type | Annual |
Ticker Symbol | GMRE | Meeting Date | 11-May-2022 |
Record Date | 15-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1.1 | | Election of Director to serve until next annual meeting: Jeffrey M. Busch | | Management | | For | | For | |
1.2 | | Election of Director to serve until next annual meeting: Matthew Cypher | | Management | | For | | For | |
1.3 | | Election of Director to serve until next annual meeting: Ronald Marston | | Management | | For | | For | |
1.4 | | Election of Director to serve until next annual meeting: Roscoe Moore, Jr. | | Management | | For | | For | |
1.5 | | Election of Director to serve until next annual meeting: Henry E. Cole | | Management | | For | | For | |
1.6 | | Election of Director to serve until next annual meeting: Zhang Huiqi | | Management | | For | | For | |
1.7 | | Election of Director to serve until next annual meeting: Paula R. Crowley | | Management | | For | | For | |
1.8 | | Election of Director to serve until next annual meeting: Lori Wittman | | Management | | For | | For | |
2. | | Advisory vote to approve the compensation of the Company's named executive officers as described in the accompanying Proxy Statement. | | Management | | For | | For | |
3. | | To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2022. | | Management | | For | | For | |
Security | 40131M109 | Meeting Type | Annual |
Ticker Symbol | GH | Meeting Date | 15-Jun-2022 |
Record Date | 18-Apr-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Class I Director: Vijaya Gadde | | Management | | For | | For | |
1B. | | Election of Class I Director: Myrtle Potter | | Management | | For | | For | |
2. | | Ratification of the appointment of Ernst & Young LLP as Guardant Health, Inc.'s independent registered public accounting firm for the year ending December 31, 2022. | | Management | | For | | For | |
3. | | Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation. | | Management | | For | | For | |
Security | 40412C101 | Meeting Type | Annual |
Ticker Symbol | HCA | Meeting Date | 21-Apr-2022 |
Record Date | 25-Feb-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: Thomas F. Frist III | | Management | | For | | For | |
1B. | | Election of Director: Samuel N. Hazen | | Management | | For | | For | |
1C. | | Election of Director: Meg G. Crofton | | Management | | For | | For | |
1D. | | Election of Director: Robert J. Dennis | | Management | | For | | For | |
1E. | | Election of Director: Nancy-Ann DeParle | | Management | | For | | For | |
1F. | | Election of Director: William R. Frist | | Management | | For | | For | |
1G. | | Election of Director: Charles O. Holliday, Jr. | | Management | | For | | For | |
1H. | | Election of Director: Hugh F. Johnston | | Management | | For | | For | |
1I. | | Election of Director: Michael W. Michelson | | Management | | For | | For | |
1J. | | Election of Director: Wayne J. Riley, M.D. | | Management | | For | | For | |
1K. | | Election of Director: Andrea B. Smith | | Management | | For | | For | |
2. | | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2022. | | Management | | For | | For | |
3. | | Advisory vote to approve named executive officer compensation. | | Management | | For | | For | |
4. | | Stockholder proposal, if properly presented at the meeting, regarding political spending disclosure. | | Shareholder | | Against | | For | |
5. | | Stockholder proposal, if properly presented at the meeting, regarding lobbying disclosure. | | Shareholder | | Against | | For | |
HEALTHCARE REALTY TRUST INCORPORATED |
Security | 421946104 | Meeting Type | Annual |
Ticker Symbol | HR | Meeting Date | 10-May-2022 |
Record Date | 16-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1. | Todd J. Meredith | | | | For | | For | |
| | 2. | John V. Abbott | | | | For | | For | |
| | 3. | Nancy H. Agee | | | | For | | For | |
| | 4. | Edward H. Braman | | | | For | | For | |
| | 5. | Ajay Gupta | | | | For | | For | |
| | 6. | James J. Kilroy | | | | For | | For | |
| | 7. | Peter F. Lyle, Sr. | | | | For | | For | |
| | 8. | John Knox Singleton | | | | For | | For | |
| | 9. | Christann M. Vasquez | | | | For | | For | |
2. | | To ratify the appointment of BDO USA, LLP as the independent registered public accounting firm for the Company and its subsidiaries for the Company's 2022 fiscal year. | | Management | | For | | For | |
3. | | To approve, on a non-binding advisory basis, the following resolution: RESOLVED, that the shareholders of Healthcare Realty Trust Incorporated approve, on a non-binding advisory basis, the compensation of the Named Executive Officers as disclosed pursuant to Item 402 of Regulation S-K in the Company's proxy statement for the 2022 Annual Meeting of Shareholders. | | Management | | For | | For | |
HEALTHCARE REALTY TRUST INCORPORATED |
Security | 421946104 | Meeting Type | Special |
Ticker Symbol | HR | Meeting Date | 15-Jul-2022 |
Record Date | 10-Jun-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1. | | To approve the merger of HR Acquisition 2, LLC, a Maryland limited liability company and a direct, wholly- owned subsidiary of Healthcare Trust of America, Inc., a Maryland corporation (the "Company"), with and into Healthcare Realty Trust Incorporated, a Maryland Corporation ("HR"),with HR continuing as the surviving entity and a direct, wholly-owned subsidiary of the Company, pursuant to which each outstanding share of HR common stock will be exchanged for one newly- issued share of the Company's class A common stock. | | Management | | For | | For | |
2. | | To approve the adjournment of the special meeting, if necessary or appropriate, including to solicit additional proxies in favor of Proposal 1 if there are insufficient votes at the time of such adjournment to approve Proposal 1. | | Management | | For | | For | |
Security | 42226A107 | Meeting Type | Annual |
Ticker Symbol | HQY | Meeting Date | 23-Jun-2022 |
Record Date | 29-Apr-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1a. | | Robert Selander | | Management | | For | | For | |
1b. | | Jon Kessler | | Management | | For | | For | |
1c. | | Stephen Neeleman, M.D. | | Management | | For | | For | |
1d. | | Frank Corvino | | Management | | For | | For | |
1e. | | Adrian Dillon | | Management | | For | | For | |
1f. | | Evelyn Dilsaver | | Management | | For | | For | |
1g. | | Debra McCowan | | Management | | For | | For | |
1h. | | Rajesh Natarajan | | Management | | For | | For | |
1i. | | Stuart Parker | | Management | | For | | For | |
1j. | | Ian Sacks | | Management | | For | | For | |
1k. | | Gayle Wellborn | | Management | | For | | For | |
2. | | To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending January 31, 2023. | | Management | | For | | For | |
3. | | To approve, on a non-binding, advisory basis, the fiscal 2022 compensation paid to our named executive officers. | | Management | | For | | For | |
HEALTHPEAK PROPERTIES, INC.
Security | 42250P103 | Meeting Type | Annual |
Ticker Symbol | PEAK | Meeting Date | 28-Apr-2022 |
Record Date | 01-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: Brian G. Cartwright | | Management | | For | | For | |
1B. | | Election of Director: Christine N. Garvey | | Management | | For | | For | |
1C. | | Election of Director: R. Kent Griffin, Jr. | | Management | | For | | For | |
1D. | | Election of Director: David B. Henry | | Management | | For | | For | |
1E. | | Election of Director: Thomas M. Herzog | | Management | | For | | For | |
1F. | | Election of Director: Lydia H. Kennard | | Management | | For | | For | |
1G. | | Election of Director: Sara G. Lewis | | Management | | For | | For | |
1H. | | Election of Director: Katherine M. Sandstrom | | Management | | For | | For | |
2. | | Approval of 2021 executive compensation on an advisory basis. | | Management | | For | | For | |
3. | | Ratification of the appointment of Deloitte & Touche LLP as Healthpeak Properties, Inc.'s independent registered public accounting firm for the year ending December 31, 2022. | | Management | | For | | For | |
Security | 436440101 | Meeting Type | Annual |
Ticker Symbol | HOLX | Meeting Date | 10-Mar-2022 |
Record Date | 11-Jan-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: Stephen P. MacMillan | | Management | | For | | For | |
1B. | | Election of Director: Sally W. Crawford | | Management | | For | | For | |
1C. | | Election of Director: Charles J. Dockendorff | | Management | | For | | For | |
1D. | | Election of Director: Scott T. Garrett | | Management | | For | | For | |
1E. | | Election of Director: Ludwig N. Hantson | | Management | | For | | For | |
1F. | | Election of Director: Namal Nawana | | Management | | For | | For | |
1G. | | Election of Director: Christiana Stamoulis | | Management | | For | | For | |
1H. | | Election of Director: Amy M. Wendell | | Management | | For | | For | |
2. | | A non-binding advisory resolution to approve executive compensation. | | Management | | For | | For | |
3. | | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal 2022. | | Management | | For | | For | |
Security | G46188101 | Meeting Type | Annual |
Ticker Symbol | HZNP | Meeting Date | 28-Apr-2022 |
Record Date | 24-Feb-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Class II Director: Michael Grey | | Management | | For | | For | |
1B. | | Election of Class II Director: Jeff Himawan, Ph.D. | | Management | | For | | For | |
1C. | | Election of Class II Director: Susan Mahony, Ph.D. | | Management | | For | | For | |
2. | | Approval of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2022 and authorization of the Audit Committee to determine the auditors' remuneration. | | Management | | For | | For | |
3. | | Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the Proxy Statement. | | Management | | For | | For | |
4. | | Authorization for us and/or any of our subsidiaries to make market purchases or overseas market purchases of our ordinary shares. | | Management | | For | | For | |
5. | | Approval of the Amended and Restated 2020 Equity Incentive Plan. | | Management | | For | | For | |
Security | 444859102 | Meeting Type | Annual |
Ticker Symbol | HUM | Meeting Date | 21-Apr-2022 |
Record Date | 28-Feb-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A) | | Election of Director: Raquel C. Bono, M.D. | | Management | | For | | For | |
1B) | | Election of Director: Bruce D. Broussard | | Management | | For | | For | |
1C) | | Election of Director: Frank A. D'Amelio | | Management | | For | | For | |
1D) | | Election of Director: David T. Feinberg, M.D. | | Management | | For | | For | |
1E) | | Election of Director: Wayne A. I. Frederick, M.D. | | Management | | For | | For | |
1F) | | Election of Director: John W. Garratt | | Management | | For | | For | |
1G) | | Election of Director: Kurt J. Hilzinger | | Management | | For | | For | |
1H) | | Election of Director: David A. Jones, Jr. | | Management | | For | | For | |
1I) | | Election of Director: Karen W. Katz | | Management | | For | | For | |
1J) | | Election of Director: Marcy S. Klevorn | | Management | | For | | For | |
1K) | | Election of Director: William J. McDonald | | Management | | For | | For | |
1L) | | Election of Director: Jorge S. Mesquita | | Management | | For | | For | |
1M) | | Election of Director: James J. O'Brien | | Management | | For | | For | |
2) | | The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm. | | Management | | For | | For | |
3) | | Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2022 proxy statement. | | Management | | For | | For | |
Security | 45168D104 | Meeting Type | Annual |
Ticker Symbol | IDXX | Meeting Date | 11-May-2022 |
Record Date | 14-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director (Proposal One): Jonathan W. Ayers | | Management | | For | | For | |
1B. | | Election of Director (Proposal One): Stuart M. Essig, PhD | | Management | | For | | For | |
1C. | | Election of Director (Proposal One): Jonathan J. Mazelsky | | Management | | For | | For | |
1D. | | Election of Director (Proposal One): M. Anne Szostak | | Management | | For | | For | |
2. | | Ratification of Appointment of Independent Registered Public Accounting Firm. To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year (Proposal Two). | | Management | | For | | For | |
3. | | Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three). | | Management | | For | | For | |
Security | 452327109 | Meeting Type | Annual |
Ticker Symbol | ILMN | Meeting Date | 26-May-2022 |
Record Date | 31-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: Frances Arnold, Ph.D. | | Management | | For | | For | |
1B. | | Election of Director: Francis A. deSouza | | Management | | For | | For | |
1C. | | Election of Director: Caroline D. Dorsa | | Management | | For | | For | |
1D. | | Election of Director: Robert S. Epstein, M.D. | | Management | | For | | For | |
1E. | | Election of Director: Scott Gottlieb, M.D. | | Management | | For | | For | |
1F. | | Election of Director: Gary S. Guthart, Ph.D. | | Management | | For | | For | |
1G. | | Election of Director: Philip W. Schiller | | Management | | For | | For | |
1H. | | Election of Director: Susan E. Siegel | | Management | | For | | For | |
1I. | | Election of Director: John W. Thompson | | Management | | For | | For | |
2. | | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 1, 2023. | | Management | | For | | For | |
3. | | To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement. | | Management | | For | | For | |
4. | | To approve, on an advisory basis, a stockholder proposal regarding the right of stockholders to call special meetings. | | Shareholder | | Against | | For | |
5. | | To approve an amendment to our Amended and Restated Certificate of Incorporation to permit stockholders to call special meetings. | | Management | | For | | For | |
Security | 46120E602 | Meeting Type | Special |
Ticker Symbol | ISRG | Meeting Date | 20-Sep-2021 |
Record Date | 18-Aug-2021 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1. | | TO APPROVE THE COMPANY'S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FOR THE PURPOSE OF EFFECTING A THREE-FOR-ONE STOCK SPLIT. | | Management | | For | | For | |
Security | 46120E602 | Meeting Type | Annual |
Ticker Symbol | ISRG | Meeting Date | 28-Apr-2022 |
Record Date | 01-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: Craig H. Barratt, Ph.D. | | Management | | For | | For | |
1B. | | Election of Director: Joseph C. Beery | | Management | | For | | For | |
1C. | | Election of Director: Gary S. Guthart, Ph.D. | | Management | | For | | For | |
1D. | | Election of Director: Amal M. Johnson | | Management | | For | | For | |
1E. | | Election of Director: Don R. Kania, Ph.D. | | Management | | For | | For | |
1F. | | Election of Director: Amy L. Ladd, M.D. | | Management | | For | | For | |
1G. | | Election of Director: Keith R. Leonard, Jr. | | Management | | For | | For | |
1H. | | Election of Director: Alan J. Levy, Ph.D. | | Management | | For | | For | |
1I. | | Election of Director: Jami Dover Nachtsheim | | Management | | For | | For | |
1J. | | Election of Director: Monica P. Reed, M.D. | | Management | | For | | For | |
1K. | | Election of Director: Mark J. Rubash | | Management | | For | | For | |
2. | | To approve, by advisory vote, the compensation of the Company's Named Executive Officers. | | Management | | For | | For | |
3. | | The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022. | | Management | | For | | For | |
4. | | To approve the Company's Amended and Restated 2010 Incentive Award Plan. | | Management | | For | | For | |
Security | 46266C105 | Meeting Type | Annual |
Ticker Symbol | IQV | Meeting Date | 12-Apr-2022 |
Record Date | 15-Feb-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1. | John P. Connaughton | | | | For | | For | |
| | 2. | John G. Danhakl | | | | For | | For | |
| | 3. | James A. Fasano | | | | For | | For | |
| | 4. | Leslie Wims Morris | | | | For | | For | |
2. | | Amendment to Certificate of Incorporation to declassify the Board of Directors over time and provide for the annual election of all directors. | | Management | | For | | For | |
3. | | Advisory (non-binding) vote to approve executive compensation (say-on-pay). | | Management | | For | | For | |
4. | | If properly presented, a shareholder proposal regarding majority voting in uncontested director elections. | | Management | | Against | | For | |
5. | | The ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA Holdings Inc.'s independent registered public accounting firm for the year ending December 31, 2022. | | Management | | For | | For | |
Security | 478160104 | Meeting Type | Annual |
Ticker Symbol | JNJ | Meeting Date | 28-Apr-2022 |
Record Date | 01-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: Darius Adamczyk | | Management | | For | | For | |
1B. | | Election of Director: Mary C. Beckerle | | Management | | For | | For | |
1C. | | Election of Director: D. Scott Davis | | Management | | For | | For | |
1D. | | Election of Director: Ian E. L. Davis | | Management | | For | | For | |
1E. | | Election of Director: Jennifer A. Doudna | | Management | | For | | For | |
1F. | | Election of Director: Joaquin Duato | | Management | | For | | For | |
1G. | | Election of Director: Alex Gorsky | | Management | | For | | For | |
1H. | | Election of Director: Marillyn A. Hewson | | Management | | For | | For | |
1I. | | Election of Director: Hubert Joly | | Management | | For | | For | |
1J. | | Election of Director: Mark B. McClellan | | Management | | For | | For | |
1K. | | Election of Director: Anne M. Mulcahy | | Management | | For | | For | |
1L. | | Election of Director: A. Eugene Washington | | Management | | For | | For | |
1M. | | Election of Director: Mark A. Weinberger | | Management | | For | | For | |
1N. | | Election of Director: Nadja Y. West | | Management | | For | | For | |
2. | | Advisory Vote to Approve Named Executive Officer Compensation. | | Management | | For | | For | |
3. | | Approval of the Company's 2022 Long-Term Incentive Plan. | | Management | | For | | For | |
4. | | Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm for 2022. | | Management | | For | | For | |
5. | | Proposal Withdrawn (Federal Securities Laws Mandatory Arbitration Bylaw). | | Shareholder | | Against | | | |
6. | | Civil Rights, Equity, Diversity & Inclusion Audit Proposal. | | Shareholder | | Against | | For | |
7. | | Third Party Racial Justice Audit. | | Shareholder | | Against | | For | |
8. | | Report on Government Financial Support and Access to COVID-19 Vaccines and Therapeutics. | | Shareholder | | Against | | For | |
9. | | Report on Public Health Costs of Protecting Vaccine Technology. | | Shareholder | | Against | | For | |
10. | | Discontinue Global Sales of Baby Powder Containing Talc. | | Shareholder | | Against | | For | |
11. | | Request for Charitable Donations Disclosure. | | Shareholder | | Against | | For | |
12. | | Third Party Review and Report on Lobbying Activities Alignment with Position on Universal Health Coverage. | | Shareholder | | Against | | For | |
13. | | Adopt Policy to Include Legal and Compliance Costs in Incentive Compensation Metrics. | | Shareholder | | Against | | For | |
14. | | CEO Compensation to Weigh Workforce Pay and Ownership. | | Shareholder | | Against | | For | |
| | | | | | | | | | |
LABORATORY CORP. OF AMERICA HOLDINGS |
Security | 50540R409 | Meeting Type | Annual |
Ticker Symbol | LH | Meeting Date | 11-May-2022 |
Record Date | 16-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: Kerrii B. Anderson | | Management | | For | | For | |
1B. | | Election of Director: Jean-Luc Bélingard | | Management | | For | | For | |
1C. | | Election of Director: Jeffrey A. Davis | | Management | | For | | For | |
1D. | | Election of Director: D. Gary Gilliland, M.D., Ph.D. | | Management | | For | | For | |
1E. | | Election of Director: Garheng Kong, M.D., Ph.D. | | Management | | For | | For | |
1F. | | Election of Director: Peter M. Neupert | | Management | | For | | For | |
1G. | | Election of Director: Richelle P. Parham | | Management | | For | | For | |
1H. | | Election of Director: Adam H. Schechter | | Management | | For | | For | |
1I. | | Election of Director: Kathryn E. Wengel | | Management | | For | | For | |
1J. | | Election of Director: R. Sanders Williams, M.D. | | Management | | For | | For | |
2. | | To approve, by non-binding vote, executive compensation. | | Management | | For | | For | |
3. | | Ratification of the appointment of Deloitte and Touche LLP as Laboratory Corporation of America Holdings' independent registered public accounting firm for the year ending December 31, 2022. | | Management | | For | | For | |
4. | | Shareholder proposal seeking an amendment to our governing documents relating to procedural requirements in connection with shareholders' rights to call a special meeting. | | Shareholder | | Against | | For | |
Security | 502175102 | Meeting Type | Annual |
Ticker Symbol | LTC | Meeting Date | 25-May-2022 |
Record Date | 11-Apr-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director to hold office until the 2023 Annual Meeting: Cornelia Cheng | | Management | | For | | For | |
1B. | | Election of Director to hold office until the 2023 Annual Meeting: Boyd W. Hendrickson | | Management | | For | | For | |
1C. | | Election of Director to hold office until the 2023 Annual Meeting: James J. Pieczynski | | Management | | For | | For | |
1D. | | Election of Director to hold office until the 2023 Annual Meeting: Devra G. Shapiro | | Management | | For | | For | |
1E. | | Election of Director to hold office until the 2023 Annual Meeting: Wendy L. Simpson | | Management | | For | | For | |
1F. | | Election of Director to hold office until the 2023 Annual Meeting: Timothy J. Triche | | Management | | For | | For | |
2. | | Ratification of independent registered public accounting firm. | | Management | | For | | For | |
3. | | Advisory vote to approve named executive officer compensation. | | Management | | For | | For | |
Security | 58155Q103 | Meeting Type | Annual |
Ticker Symbol | MCK | Meeting Date | 23-Jul-2021 |
Record Date | 28-May-2021 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director for a one-year term: Dominic J. Caruso | | Management | | For | | For | |
1B. | | Election of Director for a one-year term: Donald R. Knauss | | Management | | For | | For | |
1C. | | Election of Director for a one-year term: Bradley E. Lerman | | Management | | For | | For | |
1D. | | Election of Director for a one-year term: Linda P. Mantia | | Management | | For | | For | |
1E. | | Election of Director for a one-year term: Maria Martinez | | Management | | For | | For | |
1F. | | Election of Director for a one-year term: Edward A. Mueller | | Management | | For | | For | |
1G. | | Election of Director for a one-year term: Susan R. Salka | | Management | | For | | For | |
1H. | | Election of Director for a one-year term: Brian S. Tyler | | Management | | For | | For | |
1I. | | Election of Director for a one-year term: Kenneth E. Washington | | Management | | For | | For | |
2. | | Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending March 31, 2022. | | Management | | For | | For | |
3. | | Advisory vote on executive compensation. | | Management | | For | | For | |
4. | | Shareholder proposal on action by written consent of shareholders. | | Shareholder | | Against | | For | |
MEDICAL PROPERTIES TRUST, INC. |
Security | 58463J304 | Meeting Type | Annual |
Ticker Symbol | MPW | Meeting Date | 26-May-2022 |
Record Date | 29-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1.1 | | Election of Director: Edward K. Aldag, Jr. | | Management | | For | | For | |
1.2 | | Election of Director: G. Steven Dawson | | Management | | For | | For | |
1.3 | | Election of Director: R. Steven Hamner | | Management | | For | | For | |
1.4 | | Election of Director: Caterina A. Mozingo | | Management | | For | | For | |
1.5 | | Election of Director: Emily W. Murphy | | Management | | For | | For | |
1.6 | | Election of Director: Elizabeth N. Pitman | | Management | | For | | For | |
1.7 | | Election of Director: D. Paul Sparks, Jr. | | Management | | For | | For | |
1.8 | | Election of Director: Michael G. Stewart | | Management | | For | | For | |
1.9 | | Election of Director: C. Reynolds Thompson, III | | Management | | For | | For | |
2. | | To ratify the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2022. | | Management | | For | | For | |
3. | | To approve the compensation of the Company's executive officers, on a non-binding basis. | | Management | | For | | For | |
4. | | To approve the Medical Properties Trust, Inc. Amended and Restated 2019 Equity Investment Plan. | | Management | | For | | For | |
Security | G5960L103 | Meeting Type | Annual |
Ticker Symbol | MDT | Meeting Date | 09-Dec-2021 |
Record Date | 14-Oct-2021 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director until the 2022 Annual General Meeting: Richard H. Anderson | | Management | | For | | For | |
1B. | | Election of Director until the 2022 Annual General Meeting: Craig Arnold | | Management | | For | | For | |
1C. | | Election of Director until the 2022 Annual General Meeting: Scott C. Donnelly | | Management | | For | | For | |
1D. | | Election of Director until the 2022 Annual General Meeting: Andrea J. Goldsmith, Ph.D. | | Management | | For | | For | |
1E. | | Election of Director until the 2022 Annual General Meeting: Randall J. Hogan, III | | Management | | For | | For | |
1F. | | Election of Director until the 2022 Annual General Meeting: Kevin E. Lofton | | Management | | For | | For | |
1G. | | Election of Director until the 2022 Annual General Meeting: Geoffrey S. Martha | | Management | | For | | For | |
1H. | | Election of Director until the 2022 Annual General Meeting: Elizabeth G. Nabel, M.D. | | Management | | For | | For | |
1I. | | Election of Director until the 2022 Annual General Meeting: Denise M. O'Leary | | Management | | For | | For | |
1J. | | Election of Director until the 2022 Annual General Meeting: Kendall J. Powell | | Management | | For | | For | |
2. | | Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2022 and authorizing, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration. | | Management | | For | | For | |
3. | | Approving, on an advisory basis, the Company's executive compensation. | | Management | | For | | For | |
4. | | Approving, on an advisory basis, the frequency of Say- on-Pay votes. | | Management | | 1 Year | | For | |
5. | | Approving the new 2021 Medtronic plc Long Term Incentive Plan. | | Management | | For | | For | |
6. | | Renewing the Board of Directors' authority to issue shares under Irish law. | | Management | | For | | For | |
7. | | Renewing the Board of Directors' authority to opt out of pre- emption rights under Irish law. | | Management | | For | | For | |
8. | | Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares. | | Management | | For | | For | |
Security | 58933Y105 | Meeting Type | Annual |
Ticker Symbol | MRK | Meeting Date | 24-May-2022 |
Record Date | 25-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: Douglas M. Baker, Jr. | | Management | | For | | For | |
1B. | | Election of Director: Mary Ellen Coe | | Management | | For | | For | |
1C. | | Election of Director: Pamela J. Craig | | Management | | For | | For | |
1D. | | Election of Director: Robert M. Davis | | Management | | For | | For | |
1E. | | Election of Director: Kenneth C. Frazier | | Management | | For | | For | |
1F. | | Election of Director: Thomas H. Glocer | | Management | | For | | For | |
1G. | | Election of Director: Risa J. Lavizzo-Mourey, M.D. | | Management | | For | | For | |
1H. | | Election of Director: Stephen L. Mayo, Ph.D. | | Management | | For | | For | |
1I. | | Election of Director: Paul B. Rothman, M.D. | | Management | | For | | For | |
1J. | | Election of Director: Patricia F. Russo | | Management | | For | | For | |
1K. | | Election of Director: Christine E. Seidman, M.D. | | Management | | For | | For | |
1L. | | Election of Director: Inge G. Thulin | | Management | | For | | For | |
1M. | | Election of Director: Kathy J. Warden | | Management | | For | | For | |
1N. | | Election of Director: Peter C. Wendell | | Management | | For | | For | |
2. | | Non-binding advisory vote to approve the compensation of our named executive officers. | | Management | | For | | For | |
3. | | Ratification of the appointment of the Company's independent registered public accounting firm for 2022. | | Management | | For | | For | |
4. | | Shareholder proposal regarding an independent board chairman. | | Shareholder | | For | | Against | |
5. | | Shareholder proposal regarding access to COVID-19 products. | | Shareholder | | Against | | For | |
6. | | Shareholder proposal regarding lobbying expenditure disclosure. | | Shareholder | | Against | | For | |
METTLER-TOLEDO INTERNATIONAL, INC. |
Security | 592688105 | Meeting Type | Annual |
Ticker Symbol | MTD | Meeting Date | 05-May-2022 |
Record Date | 07-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1.1 | | Election of Director: Robert F. Spoerry | | Management | | For | | For | |
1.2 | | Election of Director: Wah-Hui Chu | | Management | | For | | For | |
1.3 | | Election of Director: Domitille Doat-Le Bigot | | Management | | For | | For | |
1.4 | | Election of Director: Olivier A. Filliol | | Management | | For | | For | |
1.5 | | Election of Director: Elisha W. Finney | | Management | | For | | For | |
1.6 | | Election of Director: Richard Francis | | Management | | For | | For | |
1.7 | | Election of Director: Michael A. Kelly | | Management | | For | | For | |
1.8 | | Election of Director: Thomas P. Salice | | Management | | For | | For | |
2. | | RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. | | Management | | For | | For | |
3. | | ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION. | | Management | | For | | For | |
Security | 60770K107 | Meeting Type | Annual |
Ticker Symbol | MRNA | Meeting Date | 28-Apr-2022 |
Record Date | 01-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1 | Noubar Afeyan, Ph.D. | | | | For | | For | |
| | 2 | Stéphane Bancel | | | | For | | For | |
| | 3 | François Nader, M.D. | | | | For | | For | |
2. | | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | | Management | | For | | For | |
3. | | To ratify the appointment of Ernst & Young LLP as our registered independent public accounting firm for the year ending December 31, 2022. | | Management | | For | | For | |
4. | | To vote on a shareholder proposal relating to the feasibility of transferring intellectual property. | | Shareholder | | For | | Against | |
Security | 60855R100 | Meeting Type | Annual |
Ticker Symbol | MOH | Meeting Date | 04-May-2022 |
Record Date | 07-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director to hold office until the 2023 Annual Meeting: Barbara L. Brasier | | Management | | For | | For | |
1B. | | Election of Director to hold office until the 2023 Annual Meeting: Daniel Cooperman | | Management | | For | | For | |
1C. | | Election of Director to hold office until the 2023 Annual Meeting: Stephen H. Lockhart | | Management | | For | | For | |
1D. | | Election of Director to hold office until the 2023 Annual Meeting: Steven J. Orlando | | Management | | For | | For | |
1E. | | Election of Director to hold office until the 2023 Annual Meeting: Ronna E. Romney | | Management | | For | | For | |
1F. | | Election of Director to hold office until the 2023 Annual Meeting: Richard M. Schapiro | | Management | | For | | For | |
1G. | | Election of Director to hold office until the 2023 Annual Meeting: Dale B. Wolf | | Management | | For | | For | |
1H. | | Election of Director to hold office until the 2023 Annual Meeting: Richard C. Zoretic | | Management | | For | | For | |
1I. | | Election of Director to hold office until the 2023 Annual Meeting: Joseph M. Zubretsky | | Management | | For | | For | |
2. | | To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers. | | Management | | For | | For | |
3. | | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2022. | | Management | | For | | For | |
NATIONAL HEALTH INVESTORS, INC. |
Security | 63633D104 | Meeting Type | Annual |
Ticker Symbol | NHI | Meeting Date | 06-May-2022 |
Record Date | 11-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: James R. Jobe | | Management | | For | | For | |
1B. | | Election of Director: Robert G. Adams | | Management | | For | | For | |
2. | | Approve the advisory resolution approving the compensation of the named executive officers as disclosed in the accompanying Proxy Statement. | | Management | | For | | For | |
3. | | Ratify the audit committee's selection of BDO USA, LLP as independent registered public accounting firm for the year ending December 31, 2022. | | Management | | For | | For | |
NEW SENIOR INVESTMENT GROUP, INC. |
Security | 648691103 | Meeting Type | Special |
Ticker Symbol | SNR | Meeting Date | 14-Sep-2021 |
Record Date | 06-Aug-2021 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1. | | Adopt the Agreement and Plan of Merger, dated as of June 28, 2021 (as amended or otherwise modified from time to time, the "Merger Agreement"), by and among New Senior Investment Group Inc., a Delaware corporation ("New Senior"), Ventas, Inc., a Delaware corporation ("Ventas"), and Cadence Merger Sub LLC, a Delaware limited liability company and a subsidiary of Ventas, Inc. ("Merger Sub"), and thereby approve the merger of Merger Sub with and into New Senior, with New Senior continuing as the surviving corporation and a subsidiary of Ventas. | | Management | | For | | For | |
2. | | Approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to the named executive officers of New Senior in connection with transactions contemplated by the Merger Agreement. | | Management | | For | | For | |
3. | | Approve the adjournment of the special meeting of the New Senior stockholders (the "Special Meeting") from time to time, if necessary or appropriate, (i) to solicit additional proxies in favor of the proposal to adopt the Merger Agreement if there are insufficient votes at the time of such adjournment to approve such proposal or (ii) if required to enable New Senior or Ventas to comply with the requirement in the Merger Agreement to provide notice to the other party 10 business days prior to the Special Meeting | | Management | | For | | For | |
Security | N/A | Meeting Type | Written Consent |
Ticker Symbol | N/A | Meeting Date | 27-Apr-2022 |
Record Date | N/A | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1. | | Approval of the Financial Statements 2021. | | Management | | For | | For | |
2. | | Appropriation of Balance Sheet Results 2021. | | Management | | For | | For | |
3. | | Discharge of the Members of the Board and Management. | | Management | | For | | For | |
4. | | Re-Election of the Board of Directors: | | | | | | | |
4.1 | | Mr. Anthony (Tony) Rosenberg | | Management | | For | | For | |
4.2 | | Dr. Riad Sherif | | Management | | For | | For | |
4.3 | | Mr. Àrni Audunn Blöndal | | Management | | For | | For | |
4.4 | | Mr. Lionel Carnot | | Management | | For | | For | |
4.5 | | Mr. Bartosz Dzikowski | | Management | | For | | For | |
4.6 | | Dr. Xin (Sylvia) He | | Management | | For | | For | |
4.7 | | Dr. Robert Lorne Hopfner | | Management | | For | | For | |
4.8 | | Ms. Yi Fei (Vanessa) Huang | | Management | | For | | For | |
4.9 | | Dr. Henry Skinner | | Management | | For | | For | |
5. | | Re-Election of the Auditors PricewaterhouseCoopers SA. | | Management | | For | | For | |
Security | N/A | Meeting Type | Extraordinary General Meeting |
Ticker Symbol | N/A | Meeting Date | 30-Nov-2021 |
Record Date | N/A | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1. | | Ordinary share capital increase | | Management | | For | | For | |
2. | | Conditional capital share increase | | Management | | For | | For | |
OMEGA HEALTHCARE INVESTORS, INC. |
Security | 681936100 | Meeting Type | Annual |
Ticker Symbol | OHI | Meeting Date | 03-Jun-2022 |
Record Date | 06-Apr-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: Kapila K. Anand | | Management | | For | | For | |
1B. | | Election of Director: Craig R. Callen | | Management | | For | | For | |
1C. | | Election of Director: Dr. Lisa C. Egbuonu-Davis | | Management | | For | | For | |
1D. | | Election of Director: Barbara B. Hill | | Management | | For | | For | |
1E. | | Election of Director: Kevin J. Jacobs | | Management | | For | | For | |
1F. | | Election of Director: C. Taylor Pickett | | Management | | For | | For | |
1G. | | Election of Director: Stephen D. Plavin | | Management | | For | | For | |
1H. | | Election of Director: Burke W. Whitman | | Management | | For | | For | |
2. | | Ratification of Independent Auditors Ernst & Young LLP for fiscal year 2022. | | Management | | For | | For | |
3. | | Approval, on an Advisory Basis, of Executive Compensation. | | Management | | For | | For | |
Security | 690732102 | Meeting Type | Annual |
Ticker Symbol | OMI | Meeting Date | 29-Apr-2022 |
Record Date | 04-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1.1 | | Election of Director: Mark A. Beck | | Management | | For | | For | |
1.2 | | Election of Director: Gwendolyn M. Bingham | | Management | | For | | For | |
1.3 | | Election of Director: Kenneth Gardner-Smith | | Management | | For | | For | |
1.4 | | Election of Director: Robert J. Henkel | | Management | | For | | For | |
1.5 | | Election of Director: Stephen W. Klemash | | Management | | For | | For | |
1.6 | | Election of Director: Mark F. McGettrick | | Management | | For | | For | |
1.7 | | Election of Director: Edward A. Pesicka | | Management | | For | | For | |
2. | | Ratification of the appointment of KPMG LLP as the Company's independent public accounting firm for the year ending December 31, 2022 | | Management | | For | | For | |
3. | | Advisory vote to approve the compensation of the Company's named executive officers | | Management | | For | | For | |
4. | | Advisory vote on the frequency of a shareholder vote on the compensation of the Company's named executive officers | | Management | | 1 Year | | For | |
Security | 714046109 | Meeting Type | Annual |
Ticker Symbol | PKI | Meeting Date | 26-Apr-2022 |
Record Date | 28-Feb-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director for a term of one year: Peter Barrett, PhD | | Management | | For | | For | |
1B. | | Election of Director for a term of one year: Samuel R. Chapin | | Management | | For | | For | |
1C. | | Election of Director for a term of one year: Sylvie Grégoire, PharmD | | Management | | For | | For | |
1D. | | Election of Director for a term of one year: Alexis P. Michas | | Management | | For | | For | |
1E. | | Election of Director for a term of one year: Prahlad R. Singh, PhD | | Management | | For | | For | |
1F. | | Election of Director for a term of one year: Michel Vounatsos | | Management | | For | | For | |
1G. | | Election of Director for a term of one year: Frank Witney, PhD | | Management | | For | | For | |
1H. | | Election of Director for a term of one year: Pascale Witz | | Management | | For | | For | |
2. | | To ratify the selection of Deloitte & Touche LLP as PerkinElmer's independent registered public accounting firm for the current fiscal year. | | Management | | For | | For | |
3. | | To approve, by non-binding advisory vote, our executive compensation. | | Management | | For | | For | |
Security | G97822103 | Meeting Type | Annual |
Ticker Symbol | PRGO | Meeting Date | 06-May-2022 |
Record Date | 07-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Bradley A. Alford | | Management | | For | | For | |
1B. | | Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Orlando D. Ashford | | Management | | For | | For | |
1C. | | Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Katherine C. Doyle | | Management | | For | | For | |
1D. | | Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Adriana Karaboutis | | Management | | For | | For | |
1E. | | Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Murray S. Kessler | | Management | | For | | For | |
1F. | | Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Jeffrey B. Kindler | | Management | | For | | For | |
1G. | | Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Erica L. Mann | | Management | | For | | For | |
1H. | | Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Donal O'Connor | | Management | | For | | For | |
1I. | | Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Geoffrey M. Parker | | Management | | For | | For | |
1J. | | Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Theodore R. Samuels | | Management | | For | | For | |
2. | | Ratify, in a non-binding advisory vote, the appointment of Ernst & Young LLP as the Company's independent auditor, and authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor | | Management | | For | | For | |
3. | | Advisory vote on executive compensation | | Management | | For | | For | |
4. | | Amend the Company's Long-Term Incentive Plan | | Management | | For | | For | |
5. | | Renew the Board's authority to issue shares under Irish law | | Management | | For | | For | |
6. | | Renew the Board's authority to opt-out of statutory pre- emption rights under Irish law | | Management | | For | | For | |
Security | 717081103 | Meeting Type | Annual |
Ticker Symbol | PFE | Meeting Date | 28-Apr-2022 |
Record Date | 02-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: Ronald E. Blaylock | | Management | | For | | For | |
1B. | | Election of Director: Albert Bourla | | Management | | For | | For | |
1C. | | Election of Director: Susan Desmond-Hellmann | | Management | | For | | For | |
1D. | | Election of Director: Joseph J. Echevarria | | Management | | For | | For | |
1E. | | Election of Director: Scott Gottlieb | | Management | | For | | For | |
1F. | | Election of Director: Helen H. Hobbs | | Management | | For | | For | |
1G. | | Election of Director: Susan Hockfield | | Management | | For | | For | |
1H. | | Election of Director: Dan R. Littman | | Management | | For | | For | |
1I. | | Election of Director: Shantanu Narayen | | Management | | For | | For | |
1J. | | Election of Director: Suzanne Nora Johnson | | Management | | For | | For | |
1K. | | Election of Director: James Quincey | | Management | | For | | For | |
1L. | | Election of Director: James C. Smith | | Management | | For | | For | |
2. | | Ratify the selection of KPMG LLP as independent registered public accounting firm for 2022 | | Management | | For | | For | |
3. | | 2022 advisory approval of executive compensation | | Management | | For | | For | |
4. | | Shareholder proposal regarding amending proxy access | | Shareholder | | Against | | For | |
5. | | Shareholder proposal regarding report on political expenditures congruency | | Shareholder | | Against | | For | |
6. | | Shareholder proposal regarding report on transfer of intellectual property to potential COVID-19 manufacturers | | Shareholder | | Against | | For | |
7. | | Shareholder proposal regarding report on board oversight of risks related to anticompetitive practices | | Shareholder | | Against | | For | |
8. | | Shareholder proposal regarding report on public health costs of protecting vaccine technology | | Shareholder | | Against | | For | |
Security | 71943U104 | Meeting Type | Annual |
Ticker Symbol | DOC | Meeting Date | 03-May-2022 |
Record Date | 24-Feb-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1.1 | | Election of Trustee: John T. Thomas | | Management | | For | | For | |
1.2 | | Election of Trustee: Tommy G. Thompson | | Management | | For | | For | |
1.3 | | Election of Trustee: Stanton D. Anderson | | Management | | For | | For | |
1.4 | | Election of Trustee: Mark A. Baumgartner | | Management | | For | | For | |
1.5 | | Election of Trustee: Albert C. Black, Jr. | | Management | | For | | For | |
1.6 | | Election of Trustee: William A. Ebinger, M.D. | | Management | | For | | For | |
1.7 | | Election of Trustee: Pamela J. Kessler | | Management | | For | | For | |
1.8 | | Election of Trustee: Ava E. Lias-Booker | | Management | | For | | For | |
1.9 | | Election of Trustee: Richard A. Weiss | | Management | | For | | For | |
2. | | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022. | | Management | | For | | For | |
3. | | To approve, on a non-binding advisory basis, the compensation paid to the Company's named executive officers. | | Management | | For | | For | |
4. | | To approve, on a non-binding advisory basis, the frequency of casting future votes on the compensation paid to the Company's named executive officers. | | Management | | 1 Year | | For | |
Security | 749397105 | Meeting Type | Annual |
Ticker Symbol | RCM | Meeting Date | 26-May-2022 |
Record Date | 06-Apr-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1. | Agnes Bundy Scanlan | | | | For | | For | |
| | 2. | David M. Dill | | | | For | | For | |
| | 3. | Michael C. Feiner | | | | For | | For | |
| | 4. | Joseph Flanagan | | | | For | | For | |
| | 5. | John B. Henneman III | | | | For | | For | |
| | 6. | Neal Moszkowski | | | | For | | For | |
| | 7. | Ian Sacks | | | | For | | For | |
| | 8. | Jill Smith | | | | For | | For | |
| | 9. | Anthony J. Speranzo | | | | For | | For | |
| | 10. | Anthony R. Tersigni | | | | For | | For | |
| | 11. | Albert R. Zimmerli | | | | For | | For | |
2. | | To approve, for purposes of complying with the applicable provisions of Nasdaq Listing Rule 5635, the issuance of shares of common stock of Project Roadrunner Parent Inc. ("New R1") to CoyCo 1, L.P. and CoyCo 2, L.P., pursuant to the terms of the Transaction Agreement and Plan of Merger, dated as of January 9, 2022, by and among the Company, New R1, Project Roadrunner Merger Sub Inc., Revint Holdings, LLC ("Cloudmed"), CoyCo 1, L.P., CoyCo 2., L.P., and certain other parties, as described in the accompanying proxy statement/prospectus. | | Management | | For | | For | |
3. | | To approve the adoption of an amendment to the Company's Restated Certificate of Incorporation to increase our authorized share capital from 500,000,000 shares to 750,000,000 shares of common stock. | | Management | | For | | For | |
4. | | To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022. | | Management | | For | | For | |
5. | | To approve the adjournment of the 2022 Annual Meeting to a later date, or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for the approval of one or more proposals at the 2022 Annual Meeting. | | Management | | For | | For | |
Security | 75120L100 | Meeting Type | Annual |
Ticker Symbol | RLYB | Meeting Date | 24-May-2022 |
Record Date | 30-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1.1 | | Election of Class I Director: Martin W. Mackay | | Management | | For | | For | |
1.2 | | Election of Class I Director: Kush M. Parmar | | Management | | For | | For | |
1.3 | | Election of Class I Director: Paula Soteropoulos | | Management | | For | | For | |
2. | | Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm. | | Management | | For | | For | |
REGENERON PHARMACEUTICALS, INC. |
Security | 75886F107 | Meeting Type | Annual |
Ticker Symbol | REGN | Meeting Date | 10-Jun-2022 |
Record Date | 12-Apr-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1a. | | Election of Director: Bonnie L. Bassler, Ph.D. | | Management | | For | | For | |
1b. | | Election of Director: Michael S. Brown, M.D. | | Management | | For | | For | |
1c. | | Election of Director: Leonard S. Schleifer, M.D., Ph.D. | | Management | | For | | For | |
1d. | | Election of Director: George D. Yancopoulos, M.D., Ph.D. | | Management | | For | | For | |
2. | | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022. | | Management | | For | | For | |
3. | | Proposal to approve, on an advisory basis, executive compensation. | | Management | | For | | For | |
Security | 761152107 | Meeting Type | Annual |
Ticker Symbol | RMD | Meeting Date | 18-Nov-2021 |
Record Date | 21-Sep-2021 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Re-election of Director to serve until 2022 annual meeting: Karen Drexler | | Management | | For | | For | |
1B. | | Re-election of Director to serve until 2022 annual meeting: Michael Farrell | | Management | | For | | For | |
1C. | | Re-election of Director to serve until 2022 annual meeting: Peter Farrell | | Management | | For | | For | |
1D. | | Re-election of Director to serve until 2022 annual meeting: Harjit Gill | | Management | | For | | For | |
1E. | | Re-election of Director to serve until 2022 annual meeting: Ron Taylor | | Management | | For | | For | |
1F. | | Election of Director to serve until 2022 annual meeting: John Hernandez | | Management | | For | | For | |
1G. | | Election of Director to serve until 2022 annual meeting: Desney Tan | | Management | | For | | For | |
2. | | Ratify our selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2022. | | Management | | For | | For | |
3. | | Approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed in the proxy statement ("say-on-pay"). | | Management | | For | | For | |
SABRA HEALTH CARE REIT, INC. |
Security | 78573L106 | Meeting Type | Annual |
Ticker Symbol | SBRA | Meeting Date | 14-Jun-2022 |
Record Date | 18-Apr-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1a. | | Election of Director: Craig A. Barbarosh | | Management | | For | | For | |
1b. | | Election of Director: Katie Cusack | | Management | | For | | For | |
1c. | | Election of Director: Michael J. Foster | | Management | | For | | For | |
1d. | | Election of Director: Lynne S. Katzmann | | Management | | For | | For | |
1e. | | Election of Director: Ann Kono | | Management | | For | | For | |
1f. | | Election of Director: Jeffrey A. Malehorn | | Management | | For | | For | |
1g. | | Election of Director: Richard K. Matros | | Management | | For | | For | |
1h. | | Election of Director: Clifton J. Porter II | | Management | | For | | For | |
2. | | Ratification of the appointment of PricewaterhouseCoopers LLP as Sabra's independent registered public accounting firm for the fiscal year ending December 31, 2022. | | Management | | For | | For | |
3. | | Approval, on an advisory basis, of the compensation of Sabra's named executive officers. | | Management | | For | | For | |
SAREPTA THERAPEUTICS, INC. |
Security | 803607100 | Meeting Type | Annual |
Ticker Symbol | SRPT | Meeting Date | 02-Jun-2022 |
Record Date | 08-Apr-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1.1 | | Election of Class I Director to hold office until the 2024 Annual meeting: Kathryn Boor, Ph.D. | | Management | | For | | For | |
1.2 | | Election of Class I Director to hold office until the 2024 Annual meeting: Michael Chambers | | Management | | For | | For | |
1.3 | | Election of Class I Director to hold office until the 2024 Annual meeting: Douglas S. Ingram | | Management | | For | | For | |
1.4 | | Election of Class I Director to hold office until the 2024 Annual meeting: Hans Wigzell, M.D., Ph.D. | | Management | | For | | For | |
2. | | To hold an advisory vote to approve, on a non-binding basis, named executive officer compensation. | | Management | | For | | For | |
3. | | To approve an amendment to the Company's 2018 Equity Incentive Plan (the "2018 Plan") to increase the maximum aggregate number of shares of common stock that may be issued pursuant to awards granted under the 2018 Plan by 2,500,000 shares to 10,687,596 shares. | | Management | | For | | For | |
4. | | To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the current year ending December 31, 2022. | | Management | | For | | For | |
Security | 81181C104 | Meeting Type | Annual |
Ticker Symbol | SGEN | Meeting Date | 13-May-2022 |
Record Date | 17-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Class III Director: Ted W. Love, M.D. | | Management | | For | | For | |
1B. | | Election of Class III Director: Daniel G. Welch | | Management | | For | | For | |
2. | | Approve, on an advisory basis, the compensation of Seagen's named executive officers as disclosed in the accompanying proxy statement. | | Management | | For | | For | |
3. | | Ratify the appointment of PricewaterhouseCoopers LLP as Seagen's independent registered public accounting firm for the fiscal year ending December 31, 2022. | | Management | | For | | For | |
Security | G8473T100 | Meeting Type | Annual |
Ticker Symbol | STE | Meeting Date | 29-Jul-2021 |
Record Date | 01-Jun-2021 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Re-election of Director: Richard C. Breeden | | Management | | For | | For | |
1B. | | Re-election of Director: Daniel A. Carestio | | Management | | For | | For | |
1C. | | Re-election of Director: Cynthia L. Feldmann | | Management | | For | | For | |
1D. | | Re-election of Director: Christopher Holland | | Management | | For | | For | |
1E. | | Re-election of Director: Dr. Jacqueline B. Kosecoff | | Management | | For | | For | |
1F. | | Re-election of Director: Paul E. Martin | | Management | | For | | For | |
1G. | | Re-election of Director: Dr. Nirav R. Shah | | Management | | For | | For | |
1H. | | Re-election of Director: Dr. Mohsen M. Sohi | | Management | | For | | For | |
1I. | | Re-election of Director: Dr. Richard M. Steeves | | Management | | For | | For | |
2. | | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending March 31, 2022. | | Management | | For | | For | |
3. | | To appoint Ernst & Young Chartered Accountants as the Company's Irish statutory auditor under the Act to hold office until the conclusion of the Company's next Annual General Meeting. | | Management | | For | | For | |
4. | | To authorize the Directors of the Company or the Audit Committee to determine the remuneration of Ernst & Young Chartered Accountants as the Company's Irish statutory auditor. | | Management | | For | | For | |
5. | | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed pursuant to the disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis and the tabular and narrative disclosure contained in the Company's proxy statement dated June 14, 2021. | | Management | | For | | For | |
Security | 863667101 | Meeting Type | Annual |
Ticker Symbol | SYK | Meeting Date | 04-May-2022 |
Record Date | 07-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A) | | Election of Director: Mary K. Brainerd | | Management | | For | | For | |
1B) | | Election of Director: Giovanni Caforio, M.D. | | Management | | For | | For | |
1C) | | Election of Director: Srikant M. Datar, Ph.D. | | Management | | For | | For | |
1D) | | Election of Director: Allan C. Golston (Lead Independent Director) | | Management | | For | | For | |
1E) | | Election of Director: Kevin A. Lobo (Chair of the Board, Chief Executive Officer and President) | | Management | | For | | For | |
1F) | | Election of Director: Sherilyn S. McCoy | | Management | | For | | For | |
1G) | | Election of Director: Andrew K. Silvernail | | Management | | For | | For | |
1H) | | Election of Director: Lisa M. Skeete Tatum | | Management | | For | | For | |
1I) | | Election of Director: Ronda E. Stryker | | Management | | For | | For | |
1J) | | Election of Director: Rajeev Suri | | Management | | For | | For | |
2) | | Ratification of Appointment of our Independent Registered Public Accounting Firm. | | Management | | For | | For | |
3) | | Advisory Vote to Approve Named Executive Officer Compensation. | | Management | | For | | For | |
4) | | Shareholder Proposal to Amend Proxy Access Terms. | | Shareholder | | Against | | For | |
Security | 87166B102 | Meeting Type | Annual |
Ticker Symbol | SYNH | Meeting Date | 25-May-2022 |
Record Date | 28-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: Todd M. Abbrecht | | Management | | For | | For | |
1B. | | Election of Director: John M. Dineen | | Management | | For | | For | |
1C. | | Election of Director: William E. Klitgaard | | Management | | For | | For | |
1D. | | Election of Director: David S. Wilkes, M.D. | | Management | | For | | For | |
2. | | To approve an amendment to the Certificate of Incorporation to phase-out the classified board structure and provide that all directors elected at or after the 2025 annual meeting of stockholders be elected on an annual basis. | | Management | | For | | For | |
3. | | To approve, on an advisory (nonbinding) basis, our executive compensation. | | Management | | For | | For | |
4. | | To approve, on an advisory (nonbinding) basis, the frequency of future stockholder advisory votes on executive compensation. | | Management | | 1 Year | | For | |
5. | | To ratify the appointment of the Company's independent auditors Deloitte & Touche LLP. | | Management | | For | | For | |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED |
Security | 881624209 | Meeting Type | Annual |
Ticker Symbol | TEVA | Meeting Date | 23-Jun-2022 |
Record Date | 16-May-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1a. | | Election of Director: Amir Elstein | | Management | | For | | For | |
1b. | | Election of Director: Roberto A. Mignone | | Management | | For | | For | |
1c. | | Election of Director: Dr. Perry D. Nisen | | Management | | For | | For | |
1d. | | Election of Director: Dr. Tal Zaks | | Management | | For | | For | |
2. | | To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers. | | Management | | For | | For | |
3. | | To approve Teva's Compensation Policy with respect to the Terms of Office and Employment of Teva's Executive Officers and Directors. | | Management | | For | | For | |
3A. | | Regarding proposal 3, please indicate when you vote whether or not you are a controlling shareholder of Teva and whether or not you have a personal benefit or other interest in this proposal* Mark "for" = yes or "against" = no. | | Management | | Against | | N/A | |
4. | | To approve amendments to Teva's Articles of Association. | | Management | | For | | For | |
5. | | To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until Teva's 2023 annual meeting of shareholders. | | Management | | For | | For | |
THE SELECT SECTOR SPDR TRUST |
Security | 81369Y209 | Meeting Type | Special |
Ticker Symbol | XLV | Meeting Date | 29-Oct-2021 |
Record Date | 03-Sep-2021 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1. | Allison Grant Williams | | | | For | | For | |
| | 2. | Sheila Hartnett-Devlin | | | | For | | For | |
| | 3. | James Jessee | | | | For | | For | |
| | 4. | Teresa Polley | | | | For | | For | |
| | 5. | Ashley T. Rabun | | | | For | | For | |
| | 6. | James E. Ross | | | | For | | For | |
| | 7. | Rory Tobin | | | | For | | For | |
THERMO FISHER SCIENTIFIC, INC. |
Security | 883556102 | Meeting Type | Annual |
Ticker Symbol | TMO | Meeting Date | 18-May-2022 |
Record Date | 25-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of director: Marc N. Casper | | Management | | For | | For | |
1B. | | Election of director: Nelson J. Chai | | Management | | For | | For | |
1C. | | Election of director: Ruby R. Chandy | | Management | | For | | For | |
1D. | | Election of director: C. Martin Harris | | Management | | For | | For | |
1E. | | Election of director: Tyler Jacks | | Management | | For | | For | |
1F. | | Election of director: R. Alexandra Keith | | Management | | For | | For | |
1G. | | Election of director: Jim P. Manzi | | Management | | For | | For | |
1H. | | Election of director: James C. Mullen | | Management | | For | | For | |
1I. | | Election of director: Lars R. Sorensen | | Management | | For | | For | |
1J. | | Election of director: Debora L. Spar | | Management | | For | | For | |
1K. | | Election of director: Scott M. Sperling | | Management | | For | | For | |
1L. | | Election of director: Dion J. Weisler | | Management | | For | | For | |
2. | | An advisory vote to approve named executive officer compensation. | | Management | | For | | For | |
3. | | Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2022. | | Management | | For | | For | |
UNITED THERAPEUTICS CORPORATION |
Security | 91307C102 | Meeting Type | Special |
Ticker Symbol | UTHR | Meeting Date | 30-Sep-2021 |
Record Date | 10-Aug-2021 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1. | | Approval of an amendment to our Restated Certificate of Incorporation to become a public benefit corporation. | | Management | | Abstain | | Against | |
UNITED THERAPEUTICS CORPORATION |
Security | 91307C102 | Meeting Type | Annual |
Ticker Symbol | UTHR | Meeting Date | 27-Jun-2022 |
Record Date | 28-Apr-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1a. | | Election of Director: Christopher Causey | | Management | | For | | For | |
1b. | | Election of Director: Richard Giltner | | Management | | For | | For | |
1c. | | Election of Director: Katherine Klein | | Management | | For | | For | |
1d. | | Election of Director: Ray Kurzweil | | Management | | For | | For | |
1e. | | Election of Director: Linda Maxwell | | Management | | For | | For | |
1f. | | Election of Director: Nilda Mesa | | Management | | For | | For | |
1g. | | Election of Director: Judy Olian | | Management | | For | | For | |
1h. | | Election of Director: Martine Rothblatt | | Management | | For | | For | |
1i. | | Election of Director: Louis Sullivan | | Management | | For | | For | |
2. | | Advisory resolution to approve executive compensation. | | Management | | For | | For | |
3. | | Approval of the amendment and restatement of the United Therapeutics Corporation Amended and Restated 2015 Stock Incentive Plan. | | Management | | For | | For | |
4. | | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2022. | | Management | | For | | For | |
UNIVERSAL HEALTH REALTY INCOME TRUST |
Security | 91359E105 | Meeting Type | Annual |
Ticker Symbol | UHT | Meeting Date | 08-Jun-2022 |
Record Date | 11-Apr-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1.1 | | Election of Trustee: Michael Allan Domb | | Management | | For | | For | |
1.2 | | Election of Trustee: James P. Morey | | Management | | For | | For | |
2. | | Advisory (nonbinding) vote to approve named executive officer compensation. | | Management | | For | | For | |
3. | | To ratify the selection of KPMG, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022. | | Management | | For | | For | |
UNIVERSAL HEALTH SERVICES, INC. |
Security | 913903100 | Meeting Type | Annual |
Ticker Symbol | UHS | Meeting Date | 18-May-2022 |
Record Date | 24-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1. | | Election of Director: Maria R. Singer | | Management | | For | | For | |
2. | | Proposal to approve an amendment and restatement of the Company's 2020 Omnibus Stock and Incentive Plan. | | Management | | For | | For | |
3. | | Proposal to ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022. | | Management | | For | | For | |
4. | | Stockholder Proposal regarding majority vote standard in director elections if properly presented at the meeting. | | Shareholder | | Against | | For | |
Security | 91324P102 | Meeting Type | Annual |
Ticker Symbol | UNH | Meeting Date | 06-Jun-2022 |
Record Date | 08-Apr-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1a. | | Election of Director: Timothy P. Flynn | | Management | | For | | For | |
1b. | | Election of Director: Paul R. Garcia | | Management | | For | | For | |
1c. | | Election of Director: Stephen J. Hemsley | | Management | | For | | For | |
1d. | | Election of Director: Michele J. Hooper | | Management | | For | | For | |
1e. | | Election of Director: F. William McNabb III | | Management | | For | | For | |
1f. | | Election of Director: Valerie C. Montgomery Rice, M.D. | | Management | | For | | For | |
1g. | | Election of Director: John H. Noseworthy, M.D. | | Management | | For | | For | |
1h. | | Election of Director: Andrew Witty | | Management | | For | | For | |
2. | | Advisory approval of the Company's executive compensation. | | Management | | For | | For | |
3. | | Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2022. | | Management | | For | | For | |
4. | | If properly presented at the 2022 Annual Meeting of Shareholders, the shareholder proposal seeking shareholder ratification of termination pay. | | Shareholder | | Against | | For | |
5. | | If properly presented at the 2022 Annual Meeting of Shareholders, the shareholder proposal regarding political contributions congruency report. | | Shareholder | | Against | | For | |
VENTAS, INC.
Security | 92276F100 | Meeting Type | Contested-Annual |
Ticker Symbol | VTR | Meeting Date | 27-Apr-2022 |
Record Date | 21-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1. | Melody C. Barnes | | | | For | | For | |
| | 2. | Debra A. Cafaro | | | | For | | For | |
| | 3. | Michael J. Embler | | | | For | | For | |
| | 4. | Matthew J. Lustig | | | | For | | For | |
| | 5. | Roxanne M. Martino | | | | For | | For | |
| | 6. | Marguerite M. Nader | | | | For | | For | |
| | 7. | Sean P. Nolan | | | | For | | For | |
| | 8. | Walter C. Rakowich | | | | For | | For | |
| | 9. | Robert D. Reed | | | | For | | For | |
| | 10. | James D. Shelton | | | | For | | For | |
| | 11. | Maurice S. Smith | | | | For | | For | |
2. | | Proposal to approve, on an advisory basis, the compensation of our Named Executive Officers. | | Management | | For | | For | |
3. | | Proposal to approve the Ventas, Inc. 2022 Incentive Plan. | | Management | | For | | For | |
4. | | Proposal to ratify KPMG LLP as our independent registered public accounting firm for the 2022 fiscal year. | | Management | | For | | For | |
VERTEX PHARMACEUTICALS INCORPORATED
Security | 92532F100 | Meeting Type | Annual |
Ticker Symbol | VRTX | Meeting Date | 18-May-2022 |
Record Date | 24-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: Sangeeta Bhatia | | Management | | For | | For | |
1B. | | Election of Director: Lloyd Carney | | Management | | For | | For | |
1C. | | Election of Director: Alan Garber | | Management | | For | | For | |
1D. | | Election of Director: Terrence Kearney | | Management | | For | | For | |
1E. | | Election of Director: Reshma Kewalramani | | Management | | For | | For | |
1F. | | Election of Director: Yuchun Lee | | Management | | For | | For | |
1G. | | Election of Director: Jeffrey Leiden | | Management | | For | | For | |
1H. | | Election of Director: Margaret McGlynn | | Management | | For | | For | |
1I. | | Election of Director: Diana McKenzie | | Management | | For | | For | |
1J. | | Election of Director: Bruce Sachs | | Management | | For | | For | |
1K. | | Election of Director: Suketu Upadhyay | | Management | | For | | For | |
2. | | Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2022. | | Management | | For | | For | |
3. | | Advisory vote to approve named executive office compensation. | | Management | | For | | For | |
4. | | Approval of an amendment and restatement of our 2013 Stock and Option Plan to increase the number of shares authorized for issuance under this plan by 13.5 million shares. | | Management | | For | | For | |
WATERS CORPORATION
Security | 941848103 | Meeting Type | Annual |
Ticker Symbol | WAT | Meeting Date | 24-May-2022 |
Record Date | 25-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1.1 | | Election of Director: Dr. Udit Batra, Ph.D. | | Management | | For | | For | |
1.2 | | Election of Director: Linda Baddour | | Management | | For | | For | |
1.3 | | Election of Director: Edward Conard | | Management | | For | | For | |
1.4 | | Election of Director: Dr. Pearl S. Huang, Ph.D. | | Management | | For | | For | |
1.5 | | Election of Director: Wei Jiang | | Management | | For | | For | |
1.6 | | Election of Director: Christopher A. Kuebler | | Management | | For | | For | |
1.7 | | Election of Director: Dr. Flemming Ornskov, M.D., M.P.H. | | Management | | For | | For | |
1.8 | | Election of Director: Thomas P. Salice | | Management | | For | | For | |
2. | | To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022. | | Management | | For | | For | |
3. | | To approve, by non-binding vote, executive compensation. | | Management | | For | | For | |
WELLTOWER, INC.
Security | 95040Q104 | Meeting Type | Annual |
Ticker Symbol | WELL | Meeting Date | 23-May-2022 |
Record Date | 04-Apr-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: Kenneth J. Bacon | | Management | | For | | For | |
1B. | | Election of Director: Karen B. DeSalvo | | Management | | For | | For | |
1C. | | Election of Director: Philip L. Hawkins | | Management | | For | | For | |
1D. | | Election of Director: Dennis G. Lopez | | Management | | For | | For | |
1E. | | Election of Director: Shankh Mitra | | Management | | For | | For | |
1F. | | Election of Director: Ade J. Patton | | Management | | For | | For | |
1G. | | Election of Director: Diana W. Reid | | Management | | For | | For | |
1H. | | Election of Director: Sergio D. Rivera | | Management | | For | | For | |
1I. | | Election of Director: Johnese M. Spisso | | Management | | For | | For | |
1J. | | Election of Director: Kathryn M. Sullivan | | Management | | For | | For | |
2. | | To amend the Certificate of Incorporation of Welltower OP Inc. to remove the provision requiring Welltower Inc. shareholders to approve amendments to the Welltower OP Inc. Certificate of Incorporation and other extraordinary transactions involving Welltower OP Inc. | | Management | | For | | For | |
3. | | The ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the year ending December 31, 2022. | | Management | | For | | For | |
4. | | The approval, on an advisory basis, of the compensation of our named executive officers as disclosed in the 2022 Proxy Statement. | | Management | | For | | For | |
ZIMMER BIOMET HOLDINGS, INC.
Security | 98956P102 | Meeting Type | Annual |
Ticker Symbol | ZBH | Meeting Date | 13-May-2022 |
Record Date | 14-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: Christopher B. Begley | | Management | | For | | For | |
1B. | | Election of Director: Betsy J. Bernard | | Management | | For | | For | |
1C. | | Election of Director: Michael J. Farrell | | Management | | For | | For | |
1D. | | Election of Director: Robert A. Hagemann | | Management | | For | | For | |
1E. | | Election of Director: Bryan C. Hanson | | Management | | For | | For | |
1F. | | Election of Director: Arthur J. Higgins | | Management | | For | | For | |
1G. | | Election of Director: Maria Teresa Hilado | | Management | | For | | For | |
1H. | | Election of Director: Syed Jafry | | Management | | For | | For | |
1I. | | Election of Director: Sreelakshmi Kolli | | Management | | For | | For | |
1J. | | Election of Director: Michael W. Michelson | | Management | | For | | For | |
2. | | Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2022. | | Management | | For | | For | |
3. | | Approve, on a non-binding advisory basis, named executive officer compensation ("Say on Pay"). | | Management | | For | | For | |
ZOETIS, INC.
Security | 98978V103 | Meeting Type | Annual |
Ticker Symbol | ZTS | Meeting Date | 19-May-2022 |
Record Date | 25-Mar-2022 | | |
Item | | Proposal | | Proposed by | | Vote | | For/Against Management | |
1A. | | Election of Director: Paul M. Bisaro | | Management | | For | | For | |
1B. | | Election of Director: Frank A. D'Amelio | | Management | | For | | For | |
1C. | | Election of Director: Michael B. McCallister | | Management | | For | | For | |
2. | | Advisory vote to approve our executive compensation. | | Management | | For | | For | |
3. | | Approval of an Amendment and Restatement of our 2013 Equity and Incentive Plan. | | Management | | For | | For | |
4. | | Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2022. | | Management | | For | | For | |
5. | | Approval of an amendment to our Restated Certificate of Incorporation to eliminate supermajority voting provisions and certain provisions related to Pfizer Inc. | | Management | | For | | For | |
6. | | Approval of an amendment to our Restated Certificate of Incorporation to declassify the Board of Directors. | | Management | | For | | For | |
SIGNATURES
Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
(Registrant) | Tekla Healthcare Opportunites Fund | |
| | |
By (Signature and Title)* | | |
| | |
| /s/ Daniel R. Omstead | |
| (Daniel R. Omstead, President) | |
| | |
Date | 8/19/22 | |
| | | | |
*Print the name and title of each signing officer under his or her signature.